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MOLECULAR DISSECTION OF KIF15 
SUMMARY 
Kif15, member of kinesin motor protein family, opposes to the forces generated by 
other motors that move microtubules (MTs) to maintain the separation of spindle 
poles in mitotic cells. Kif15 motor domain interacts with MTs, while its tail domain 
interacts with other MTs or actin filaments, depending on the phase of mitosis.  
Kif15 is also found in neurons, but there its function is still a mystery. Many neurons 
are born far from their ultimate destinations and have to migrate to their target 
places. When neurons arrive to their target places, the forces generated by other 
motors that affect migration, have to be neutralized. It is thought that Kif15 
crosslinks MTs and microfilaments (MFs), and as a result they oppose the capacity 
of other motors to generate independent MT movements. 
The aim of the project is to specifically identify the domains of Kif15 that interact 
with the above mentioned cytoskeletal elements, and ultimately to understand the 
molecular mechanisms of neuronal migration and neuronal diseases like 
Lissencephaly caused by abnormalities during migration. 
For this reason, an adult rat was dissected and whole brain was obtained. RNA 
isolation was performed from the whole brain. cDNA was synthesized by using the 
total RNA as a template. Then, functional domains (motor, myosin interacting and  
tail domains) of Kif 15 was amplified by using sequence specific primers. Sequences 
of the clones were verified and then, these domains were subcloned into fluorescent 
expression vectors in order to be used in cell culture studies. 
Ongoing experiments include transfection of HeLa and primary neurons by GFP 
constructs, immunostaining and fluorescent microscopy studies. 
 
 xiv 
KİF15’İN MOLEKÜLER DİSEKSİYONU 
ÖZET 
Kinezin motor protein ailesinin bir üyesi olan Kif15, mitotik hücrelerde, diğer motor 
proteinler tarafından yaratılan kuvvetlere karşı koyarak mitoz mekiğinin stabilitesini 
sağlar. Kif15’in motor bölgesi mikrotübüllerle etkileşirken, kuyruk kısmı -mitozun 
evresine bağlı olarak-  mikrotübüller veya aktin filamentleriyle etkileşir. 
Kif15 nöronlarda da bulunur ama buradaki fonksiyonu halen bilinmemektedir. 
Organizmanın gelişimi sırasında merkezi sinir sisteminden menşe alan nöronların 
görevlerini yerine getirebilmeleri için hedef yerlerine ulaşmaları, yani göç etmeleri 
gerekmektedir. Nöronlar hedef yerlerine geldiklerinde, nöronal göçte etkili diğer 
motor proteinlerinin yarattığı kuvvetler nötralize edilmelidir. Kif15’in de motor 
kısmıyla mikrotübüllere bağlanıp, kuyruk kısmıyla da diğer mikrotübüller ve/veya 
aktin filamentleriyle etkileşerek bu ağın stabilizasyonunu sağladığı ve böylece 
nöronal göçün durdurulmasında önemli rol oynadığı düşünülmektedir.  
Bu projenin amacı, Kif 15’in özellikle yukarıda bahsedilen sitoiskelet elemanlarıyla 
etkileşen bölgelerini ayrı ayrı tanımlamak, ve sonunda nöronal göçün ve bu sırada 
meydana gelen anormallikler sonrası oluşan Lissencephaly gibi nöronal hastalıkların 
moleküler mekanizmasını anlamaktır. 
Bu amaçla ergin bir sıçan disekte edildi ve beyin bölgesi alındı. Bu beyin 
kullanılarak total RNA izolasyonu yapıldı. Elde edilen RNA’dan cDNA sentezlendi 
ve diziye özel primerler kullanılarak Kif15’in özelleşmiş fonksiyonu olan bölgeleri 
(motor, myosinle etkileştiği düşünülen bölge ve kuyruk bölgeleri) klonlandı. 
Klonlama vektöründeki alt bölgeler dizileri doğrulandıktan sonra, hücre kültürü 
çalışmalarında kullanılmak üzere fluoresan ekspresyon vektörlerine aktarıldı. 
Şu an sürdürülmekte olan deneyler, HeLa ve primer nöron hücrelerinin bu 
vektörlerle transfeksiyonunu, immunositokimyasal boyama ve fluoresan mikroskobu 
çalışmalarını içermektedir. 
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1. INTRODUCTION 
1.1. Cytoskeleton 
Cells have to organize themselves and interact with their environment. The ability of 
cells to adopt a variety of shapes and to carry out coordinated and directed 
movements depends on the cytoskeleton, a complex network of protein filaments that 
extend throughout the cytoplasm [1,2]. 
 
Figure 1.1: A eukaryotic cell stained for visualizing its cytoskeleton. Blue color indicates the nucleus, 
red color indicates the actin filaments and green color indicates the microtubules. 
The cytoskeleton pulls chromosomes apart in mitosis and meiosis, splits the dividing 
cell into two, guides the intracellular traffic of organelles, supports the fragile plasma 
membrane and provides mechanical strength. In addition, it enables some cells swim 
or crawl across surfaces and it is responsible for contraction in mucsle cells and also 
it provides the machinery needed for extension of axon and dendrites in neurons  
[1-3]. 
These diverse activities of the cytoskeleton depend on three principal types of protein 
filaments: actin filaments, microtubules and intermediate filaments. Each type of 
filament is formed from a different protein monomer and can be built into a variety 
of structures according to its associated proteins. Some of the associated proteins link 
filaments to one another or to other cell components, such as the plasma membrane. 
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In addition to the cell shape and movements, the cytoskeleton controls, directly or via 
regulatory proteins, several cellular functions, comprising the decision of a cell to 
enter the cell cycle or the apoptotic death pathway [1,3,4]. 
1.1.1. Microfilaments (Actin Filaments) 
The actin cytoskeleton is a dynamic structure that participates in cellular functions 
including the maintenance of cell polarity and morphology, intracellular trafficking 
of organelles, cell motility, and cell division [5,7]. 
 
Figure 1.2:  Actin filaments stained with green fluorescent proteins. 
Actin subunit is a single globular polypeptide chain termed “G-actin” which has an 
ATP binding site at the centre of the molecule. ATP is hydrolyzed immediately after 
the molecule is incorporated into an actin filament. The ADP is trapped in the actin 
filament until it depolymerizes. Then an exchange can occur. This monomer 
dimerizes or forms a trimer and serves as nucleation site for further growth of the 
actin protofilament. As a result, the actin subunits assemble head-to-tail to generate 
filaments with a distinct structural polarity termed “ F-actin” [1, 6, 8]. 
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                               -A-                           -B-             -C-                    -D- 
Figure 1.3: A) shows actin polymerization and depolymerization B) shows globular actin, G-Actin             
C) shows filamentous actin, F-actin D) shows the 3D structure of F-actin    
G-actin forms F-actin (the filament) in the presence of ATP, Mg+2 and K+. The 
concentration of G-actin is also critical.  Above the critical concentration of G-actin, 
the molecules will polymerize.  Below the critical concentration, the actin filaments 
will depolymerize. ATP hydrolysis is not required for polymerization, but it is 
required to promote depolymerization (when it is converted to ADP). Growth and 
polymerization are more rapid at the plus end.  
Actin filaments consist of two paralel protofilaments that twist around each other in a 
right-handed helix. In living cells they are cross-linked and bundled together via 
different accessory proteins [1, 2, 6]. 
 
Figure 1.4: Cross-linking of actin filaments via different accessory proteins. 
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1.1.2. Intermediate Filaments 
Although all eukaryotic cells contain microtubules and microfilaments, intermediate 
filaments are found in only some of them. These filaments have mechanical  
properties that are especially useful to animals that have  soft-bodies and no 
exoskeleton, such as nematodes and vertebrates. Intermediate filaments are 
particularly prominent in the cytoplasm of the cells that are subjected to mechanical 
stress. Thus their major function is thought to be to impart physical strength to cells 
and tissues. 
 
 
 
 
Figure 1.5: The intermediate filaments of keratin in epithelial cells stained with a fluorescent stain. 
Intermediate filament proteins form parallel homo or heterodimers with a highly 
conserved coiled-coil core domain and nonhelical tails and heads. A tetramer is 
formed by antiparallel, staggered side-by-side aggregation of two identical dimers. 
Since tetrameric subunit is made up of two dimers pointing in opposite direction, its 
two ends are the same. Thus, the assembled intermediate filament lacks the overall 
structural polarity that is critical for both microtubule and microfilaments. Tetramers 
aggregate end to end, forming a protofilament; pairs of protofilaments then laterally 
associate into a protofibril. Lateral association of four protofibrils form a cylindrical 
intermediate filament in10 nm thickness [1,9]. 
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Figure 1.6: Levels of organization and assembly of intermediate filaments 
There are several types of intermediate filaments, each constructed from one or more 
proteins characteristic for it. For example, keratins are found in epithelial cells and 
also form hair and nails, nuclear lamins form a meshwork that stabilizes the inner 
membrane of the nuclear envelope, neurofilaments strengthen the long axons of 
neurons, vimentins provide mechanical strength to muscle (and other) cells [11].  
Although for many years they were considered as stable cytoskeletal elements, many 
researches are being made to show their dynamic and motile properties[10,11]. 
1.1.3. Microtubules 
Microtubules are filamentous intracellular structures that are responsible for various 
kinds of movements in all eukaryotic cells. They are involved in nucleic and cell 
division, organization of intracellular structure, and intracellular transport, as well as 
ciliary and flagellar motility [1,2]. 
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Figure 1.7: This micrograph shows cells in culture immunolabeled with fluorescein-labeled 
antibodies for tubulin  
Microtubules are made up of α,β-tubulin heterodimers. This heterodimer does not 
come apart, once formed. The α and β tubulins which are about 55 kDa MW are 
homologous, but not identical. Each has a nucleotide binding site. α-tubulin has a 
bound molecule of GTP, that does not hydrolyze. β-tubulin may have bound GTP or 
GDP. Under certain conditions, β-tubulin can hydrolyze its bound GTP to GDP plus 
Pi, release Pi, and exchange the GDP for GTP [12, 14]. 
γ-Tubulin, which is homologous to α and β tubulins, nucleates microtubule assembly 
within the centrosome. Several (12-14) copies of γ-tubulin associate in a complex 
with other proteins called "grips" (gamma ring proteins) [1]. 
 
Figure 1.8: γ-Tubulin ring complex 
When intracellular conditions favor assembly, tubulin heterodimers assemble into 
linear protofilaments. Staggered assembly of 13 protofilaments yields a helical 
arrangement of tubulin heterodimers in the cylinder wall (24 nm in diameter). 
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Figure 1.9: Assembly of microtubules 
Microtubules are polar structures. Their minus end grows slower compared to the 
plus end, and the minus end is terminated by α tubulin subunits, while the plus end is 
terminated by β subunits. In addition, microtubules may vary in their rate of 
assembly and disassembly, and show dynamic instability [1,2]. 
If the free tubulin concentration in solution is between the critical values (the critical 
concentration (Cc) is the concentration of dimeric αβ-tubulin in equilibrium with 
microtubules.), a single microtubule end may undergo transitions between a growing 
state and a shrinking state [1]. A growing microtubule has GTP cap which nucleates  
growing. If nucleotide hydrolysis occurs more rapidly than subunit addition, this cap 
is lost and microtubule starts to shrink. This event is called “catastrophe”. 
Meanwhile, GTP containing subunits can still be added to the shrinking end, and 
form a new cap, then microtubule growth resumes. This stage is called “ rescue” 
[2,13,15]. 
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Figure 1.10: Shows polymerızation and depolymerization of microtubules, and microtubule lenght 
chancing via time intervals. (McEwen Lab.) 
Assembly and disassembly each proceeds at uniform rates, but there is a large 
difference between the rate of assembly and that of disassembly (see fig.1.10), 
During periods of growth, the microtubule elongates at a rate of 1µm/min. Abrupt 
transitions to the shrinkage stage (catastrophe) and to the elongation stage (rescue) 
are observed. The microtubule shortens much more rapidly (7µm/min) than it 
elongates [1,16]. 
In mitotic cells, microtubules are nucleated at the centrosome at their minus ends by 
microtubule organizing centre (MTOC), so the plus ends point outward and grow 
toward the cell periphery [17]. 
 
Figure 1.11:  Microtubule organization in mitotic and neuronal cells 
In neuronal cells, microtubules are found in cell body just like in their orientation in 
mitotic cells, but in axon and dendrites it  lays without an MTOC. In axons their 
minus end points cell body and their plus end points outward. In dendrites, the 
opposite orientation is also possible [2,17].  
 
 
nucleus 
MTOC 
microtubules 
(−)      (+) 
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1.2. Accessory Proteins of Cytoskeleton 
Once a cytoskeletal filament is formed by nucleation and elongation from the subunit 
pool, its stability and mechanical properties are often altered by a set of proteins that 
bind along the sides of the polymer. Different filament-associated proteins use their 
binding energy to either lower or raise the free energy of the polymer state, and they 
thereby either stabilize or destabilize the polymer, respectively [1,18]. 
1.2.1. Microtubule Associated Proteins (MAPs)  
Microtubule-associated proteins interact with the microtubules of the cellular 
cytoskeleton. MAPs bind to the tubulin subunits that make up microtubules to 
regulate their stability [19].  
The numerous identified MAPs are classified into two categories: Type I (including 
MAP1 proteins) and type II (including MAP2, MAP4 and tau proteins) [1]. The 
MAPs which have been identified in many different cell types, have a wide range of 
function. These include both stabilizing and destabilizing microtubules, guiding 
microtubules towards specific cellular locations, cross-linking microtubules and 
mediating the interactions of microtubules with other proteins in the cell [2]. 
Within the cell, MAPs bind directly to the tubulin monomers of microtubules. This 
binding can occur with either polymerized or depolymerized tubulin, and in most 
cases, this leads to the stabilization of microtubule structure, further encouraging 
polymerization [1,20]. Usually, it is the C-terminal domain of the MAP that interacts 
with tubulin, while the N-terminal domain can bind with cellular vesicles, 
intermediate filaments or other microtubules. MAP-microtubule binding is regulated 
through MAP phosphorylation. This is accomplished through the function of the 
microtubule-affinity-regulating-kinase (MARK) protein. 
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Figure 1.12 : MAP-2, a microtubule associated protein 
Phosphorylation of the MAP by the MARK causes the MAP to detach from any 
bound microtubules. This detachment is usually associated with the destabilization of 
the microtubule causing it to fall apart. In this way, the stabilization of microtubules 
by MAPs is regulated within the cell through phosphorylation [21]. 
1.2.2.  Molecular Motors 
Molecular motors or motor proteins are divided into 3 groups: Myosins,dyneins and 
kinesins. Myosins are actin-based motor proteins, kinesins and dyneins are 
microtubule-based motor proteins. Motor proteins are able to recognize the 
microtubule polarity. Therefore, organization of the rails combined with the specific 
motor  determines the direction of transport [23]. 
They all have a globular motor domain which interacts with microtubules and 
microfilaments. They move along these polarized cytoskeletal “highways” by using 
the mechanical energy converted from ATP hydrolysis and they carry their ‘cargoes’ 
or bind to other cytoskeletal elements via their tail domains [22,27]. 
1.2.2.1. Myosins 
The myosins are large family of motor proteins that move along actin filaments by 
using ATP hydrolysis. The first identified motor protein was a skeletal muscle 
myosin (conventional myosin or myosin-II) which is responsible for generating the 
force for a muscle contraction. Since then, there has been extensive characterization 
of these myosins and much is known about their function [24]. 
Myosins are composed of two light and two heavy chains. Each of the heavy chains 
has a mostly conserved globular head domain at its N-terminus that contains the 
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force generating machinery. Each myosin head binds and hydrolyses ATP. They use 
the revealed energy in order to walk towards the positive end of the actin filaments. 
(Myosin VI is an exception since it moves towards the minus end). Head domain is 
followed by a long amino acid sequence that forms an extended coiled coil that 
mediates heavy chain dimerization. There are two types of light chains: essential 
light chains (ELC) and regulatory light chains (RLC). The overall activity and 
polymerization can be modulated by phosphorylation on the light chains and the C-
terminus of the heavy chains respectively. C-terminus shows diversity among 
different myosin families [25].  
 
Figure 1.13: Structure of myosin II. 
It was initially thought that myosins were only found in muscles, but then many 
others were discovered in different cell types. This reveals that myosins are not only 
responsible for generating force for contraction, they also have some other functions. 
For example myosin II is required for not only for contraction, but also for 
cytokinesis and forward translocation of the body of a cell during cell migration, 
myosin I generally involves in intracellular organization and myosin V is involved in 
vesicle and organelle transport [1,26]. 
1.2.2.2. Dyneins 
Dynein is a minus-end-directed microtubule motor that has diverse cellular 
processes. Dyneins contain one to three heavy chains. Each heavy chain consists of a 
C-terminal globular head together with two elongated flexible structures called the 
stalk and the N-terminal tail (the cargo-binding domain). Dyneins are categorized 
into two major classes, axonemal and cytoplasmic [28].  
The axonemal dynein produces the bending motions that propagate along cilia and 
flagella. They are localized in the outer doublet microtubules in the axoneme and 
 12 
form projections called dynein arms, each of which is composed of multiple dynein 
molecules [1]. 
Cytoplasmic dynein is an AAA (ATPases associated with various cellular activities) 
type molecular motor. Cytoplasmic dynein and its activator dynactin are essential in 
higher eukaryotes [27]. It moves along a single microtubule in multiple steps which 
are accompanied with multiple ATP hydrolysis [27,28]. This processive sliding is 
crucial for many fundamental cellular processes, including nuclear migration, 
organization of the mitotic spindle, chromosome separation during mitosis, and the 
positioning and function of many intracellular organelles. Especially in neurons, they 
carry out many crucial processes like; retrograde axonal transport, neurotrophic 
factor signaling, neurofilament transport, mRNA localization, neuronal migration, 
and protein recycling and degradation. Mutations in either dynein or dynactin lead to 
motor neuron degeneration and its loss [28]. 
 
 
 
 
           
       
Figure 1.14: A) Structure of a cytoplasmic dynein and dynactin complex B) Dynein movement on 
microtubules 
1.2.2.3. Kinesins 
Kinesins are a large family of positive and negative end directed motor proteins 
present in all eukaryotic phyla [28]. The kinesin superfamily proteins (KIFs) are 
microtubule based proteins that have been shown to have a wide range of functions, 
including the transport of different cargoes (vesicles, organelles, protein complexes, 
chromosomes), and the regulation of microtubule dynamics in an ATP-dependent 
manner in both mitotic and neuronal cells[33]. In addition, they participate in 
polarized transport in epithelial cells and KIFs also play significant roles in neuronal 
development [29,30]. 
A 
B
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Kinesins are mainly made up of 2 heavy chains (KHC) and 2 light chains (KLC). 
Two identical polypeptides (KHC) dimerize to form a coiled-coil stalk, with a cargo 
binding tail at one end and twin globular heads at the other [41]. Each head is a 
catalytically active ATPase that attaches to microtubules with nucleotide-dependent 
affinity. Short (15 amino acid) polypeptide segments, called neck-linkers join each 
head to the stalk [31]. 
 
Figure 1.15: Structure of kinesin [33] 
Kinesins use microtubules and microfilaments as railways. They bind to these 
cytoskeletal elements by their motor domains. They can also interact with many 
different cargoes and other cytoskeletal elements [36]. It has been shown that, 
kinesins can bind to a cargo by their tail domain directly, or this interaction can be 
mediated via adaptor/scaffolding proteins. In addition they can bind to other 
cytoskeletal elements [22]. 
 
Figure 1.16: Different  interaction ways of kinesins with different cargoes 
There are 3 major types of kinesin superfamily proteins which have been identified 
according to the position of the motor domain: NH2-terminal motor domain type (N-
type), middle motor domain type (M-type), and COOH-terminal motor domain type 
(C-type) [32, 37]. 
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Figure 1.17: Domain structures of typical members of the kinesin superfamily. A) N-type kinesin Bar 
diagram of the kinesin heavy chain B) M-type kinesin C) C-type kinesin  
Kinesins walk on microtubules or microfilaments by ATP hydrolysis. ATP binding 
to the leading head triggers docking of the neck linker onto the catalytic core and 
initiates movement towards the plus end. The trailing head is pulled forward, 
releasing Pi. Thus leading and trailing heads change their positions. Upon binding to 
the microtubule, the leading head releases its ADP, resulting in a conformational 
change that results in the hydrolysis of ATP by the trailing head. Zippering of the 
neck linker is critical to this process, with the linker docked to the catalytic core only 
when the core has bound ATP or ADP-Pi [34,38,39]. 
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Figure 1.18: A schematic model illustrating processive movement by the plus-end directed motor 
kinesin. The two kinesin heads are indicated with light pink and dark pink and the α- and β-tubulin 
subunits from a single microtubule protofilament are indicated in blue and green [34]. 
Kinesins are not always active in cells. They only become active when they are 
needed [41]. The mechanism by which this could occur is still unclear, but there are 
many hypothesis about this situation. One possible mechanism is that kinesin 
becomes active when a cargo binds to a tail domain. This releases the self-inhibition 
and allows motor-cargo complex to bind to and move on microtubules(Fig.19-a). On 
the other hand, in other models it is thought that cargo binding might not lead a direct 
activation. Additional changes might be needed such as phosphorylation of kinesin 
(Fig 19-b), pH changes (Fig 19-c) or any other cellular factors (Fig 19-d) can trigger 
this activation [36, 45]. 
 
 
 
Figure 1.19: Possible ways of kinesin activation [45] 
In addition how kinesins choose their specific cargoes and how can they leave them 
to the right place is still a mystery [42].  
There are several ways by which motor proteins may be regulated:  regulation of 
affinity to the cargo, to the cytoskeleton, or regulation of protein levels in the cell. 
Often more than one level of regulation is imposed on a single motor protein [43]. 
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Kinesin light and heavy chains can be regulated by phosphorylation, changing 
affinity for the kinesin receptor, the microtubule, or altering the efficient hydrolysis 
of ATP. Accessory factor binding to the complex can also be modulated, which in 
turn can affect kinesin activity[40, 44]. The affinity of kinectin for kinesin can also 
be regulated. Finally, the binding of microtubule-associated proteins to the 
microtubule can be regulated by phosphorylation, which alters the ability of kinesin 
to travel along the microtubule path [52]. 
 
 
 
 
 
Figure 1.20: Possible targets for regulation of kinesin dynamics [40]. 
 
 
1.2.2.4. KIF 15 
Kif15 is a member of N-type kinesin super family. Hence, it has all the general 
properties of these kinesins. In addition, since it has some crucial and intriguing roles 
in both mitotic and neuronal cells, it has become popular recently. 
Kif 15 is mainly made up of 2 heavy and 2 light chains like all other kinesins. Heavy 
chain is made up of a catalytic motor domain, neck linker, neck, stalk (coilI and coil 
II) domains, and a tail domain [45]. 
 
 
Figure 1.21: Functional domains of Kif15 
Myosin tail homology domain 
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In mitotic cells, Kif 15 interacts with microtubules and microfilaments according to 
the phase of mitosis. In interphase, it interacts with actin filaments (microfilaments), 
but not microtubules but during mitosis, from prophase to early anaphase it interacts 
with microtubules. Finally, Kif 15 enrichment has been observed in cleavage furrow 
during cytokinesis with actin filaments. 
Since its homologues crosslink microtubules by binding on them with their motor 
domain and interact with other microtubules with their tail domain, it was shown that 
Kif15 act just like its homologues in mitotic cells [46]. 
 
 
 
 
 
 
Figure 1.22: A) No co-localization of Kif 15 with microtubules in interphase B)Co-localization of 
microtubules with actin filaments in interphase 
Note: Red indicates the tubulin and actin, respectively, green indicates Kif15 yellow 
indicates the co-localization. 
A 
B 
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Figure 1.23: A) Kif 15 co-localization with microtubules from metaphase to late anaphase B)Kif 15 
co-localization with actin filaments during cytokinesis 
 
Kif 15 is also actively expressed in postmitotic neurons and it has been shown that 
Kif 15 enrichment was high in critical points where microtubules form bundles, like 
dendrites or stalled growth cones [46].  
 
Figure 1.24: Kif15 enrichment in knots of microtubules in neuronal cells 
This results revealed the possibility that Kif15 could be an important molecule for 
neuronal migration. 
A
B
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Resting place 
New born neuron 
Cell migration occurs widely at all stages of embryonic development. Migration of 
neurons during mammalian brain development is essential for the proper functioning 
of the central nervous system [47]. 
One of the remarkable features of the mammalian brain is the laminar structure of its 
neurons. The adult cerebral and cerebellar cortex consist of six and three neuronal 
layers, respectively. This intricate laminar construction is achieved by the highly 
ordered migration of postmitotic neurons, because neurons are usually generated in 
sites different from where they eventually reside, they migrate and find their resting 
places. Then, they become mature here and send out their axons and dendrites. 
Neurons migrate following three steps and they are ordered into architectonic 
patterns at the end of migration. These three steps are: 
1- Leading edge extension: proceeds at the extremity of the axon and directed 
by microfilaments. 
2- Nucleokinesis (nuclear translocation): is a process dependent on the 
microtubule network. Nucleus is carried in a unison with the cell. 
3- Retraction of the trailing process [47,49] 
 
 
 
 
 
 
 
 
 
Figure 1.25: Neuronal migration steps 
If the migrating neurons can not achive to find their final destinations or if they can 
not stop where they has to stay, abnormal neuronal development occurs and different 
kinds of neurodegeneretive diseases are observed [50]. 
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As a result, Kif 15 is thought to crosslink microtubules by interacting with its both 
motor and tail domain as it does in mitotic cells and it could play an important role in 
ending the neuronal migration by using this feature. 
1.3. Aim of the study 
Motor proteins (kinesins, dyneins and myosins) are responsible for cytoskeleton-
based transport and motor function, which have impact on all dynamic aspects of cell 
behavior including cell division, the generation and maintanence of cell polarity, cell 
signalling, and cell motility. There is an advanced balance between these forces in 
organizing the microtubule and microfilament dynamics. Thus, understanding the 
regulatory mechanisms that control motor function is important for attempts to define 
the basic cellular processes failing in numerous disease states including cancer, birth 
defects, deafness, respiratory disorders and neurodegenerative diseases. 
Kinesins are positive and negative end directed motor proteins found in all 
eukaryotic organisms which undertake crucial roles in both mitotic and neuronal 
cells. They were ones believed to exclusively transport membrane organelles, besides 
the force generation function. However, it is now known that they can also move 
many different cargoes such as cytosolic components, protein complexes, nucleic 
acids etc. 
Kinesins structurally consist of two functional parts: a motor domain that reversibly 
binds to the cytoskeleton and converts chemical energy into motion by ATP 
hydrolysis, and a tail domain that interacts with cargo directly or through an adaptor. 
Kif 15 is a member of kinesin motor family whose homologues are believed to 
crosslink and immobilize spindle microtubules. This is achieved by crosslinking 
neighboring microtubules and by exerting forces that oppose the compressive forces 
that would otherwise collapse the bipolar spindle to a monastral array. 
Kif 15 interacts with different cytoskeletal elements based on the phase of the 
mitosis. For example,  it localizes to spindle poles and microtubules from 
prometaphase to early anaphase but then to the actin-based cleavage furrow during 
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cytokinesis. Moreover, Kif15 is localized to actin bundles in interphase. This switch 
mechanism between these cytoskelatal elements is still a mystery.  
On the other hand, Kif 15 is not only found in actively dividing mitotic cells, but also 
it is expressed in terminally postmitotic neurons. Kif 15 enrichment has been 
observed in microtubule bundles that occupy stalled growth cones and dendrites. It 
has been also observed that migratory neurons contain high amounts of Kif 15 
comparing to other neurons. 
 In migrating neurons, there is a cage-like configuration of microtubules around the 
nucleus linked to the microtubule array in leading process which enables the cell to 
move in unison as it migrates. Since microtubules have the ability to move 
independently from one another, this movement is regulated by motor proteins in all 
of these cases. Hence, it is thought that Kif 15 plays a crucial role in neuronal 
migration. It achieves this by binding to the microtubules with its motor domain 
while it interacts with other microtubules with its tail domain. Thus, it is thought that 
it has an affect on ending the neuronal migration. This is of great importance for the 
proper development of the nervous system because abnormalities observed in 
neuronal migration causes diseases like Lissencephaly. 
Considering Kif15’s crucial role in both mitotic cells and neuronal cells, this protein 
was selected for the dissection on its functional domains. Understanding the 
interaction of Kif15’s motor and tail domain with other cytoskeletal elements will 
give us a clue about the complex mechanisms of neuronal migration and shed light 
on unknown features of mitosis. In addition, since Kif15 can represent other Kifs 
which have similar functions, any information gained for Kif15 will be useful for 
many others.  Finally, since motor proteins are important in intracellular transport, 
cell division, nucleokinesis, cellular and ciliary motility, cellular morphogenesis and 
neuronal migration, defects in motors can cause many diseases in both mitotic and 
neuronal cells, like Charcot-Marie-Tooth disease, Alzheimer and cancer [51].  
In order to understand all these puzzled mechanisms and ultimately to put some input 
in curing these diseases, investigating all motor proteins and the filamet network of 
cytoskeleton is necessary. Thus, molecular dissection of Kif15 for understanding the 
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interactions of its functional domains with other cytoskeletal elements will be a step 
for these purposes. 
In this study, it was aimed to reveal the cytoskeletal elements interacting with Kif 
15’s functional domains (motor, tail, myosin interacting etc. domains) by using 
cloning, cell culture and staining techniques. By this way, some information about 
how and when motor domain binds to the microtubules or microfilaments could be 
obtained. More importantly, since the tail domain is specific to all kinesins and it can 
both carry different cargoes and interacts with other cytoskeletal elements, valuable 
informations could be obtained about tail interactions. 
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1.3.1. Rat (Rattus norvegicus) Kif15 full sequence and functional domains 
Kif15 was dissected, in order to understand the functions of its functionally active 
domains. Kif15’s full sequence and the domains which were decided to be dissected 
is indicated in the table below. 
              Table 1.1: Full sequence of Kif15 and its functional domains 
atggctcctggctgcaaatctgagttacggaatgtgacaaattctcattctaaccagccaagtaacgaagatgatgccatcaaagtttt
tgtgcggattcgccctgctgaagagggcgctaggtcagctgatggagagcagagcctctgcttgtctgtgctctcccagactgctctc
cggctgcactccaacccagaccccaagacctttgtattcgattatgttgcaggcatggacaccactcaggagtctgtattttcaacagtg
gctaaaagcattgtggagtcttgcatgagtggttacaacgggaccatctttgcatatgggcagactggctctgggaagacatttactatg
atgggaccatcggactctgataatttttctcataatctaagaggagtaattccacgaagttttgaatatttgttttccttaattgatcgtgaaaa
agaaaaggctggagctgggaagagtttcctttgtaagtgctccttcattgaggtctacaatgagcagatatacgacctgctggactctg
catcggtcggactgtatttaagagagcacataaagaagggcgtcttcgtggttggtgcagtggagcaggtggtggcctcagctgctg
aagcctaccaggtcttatctagaggctggaggaacaggcgtgtagcatcaacatctatgaacagagaatcttccaggtctcatgcagt
ctttacaatcacaatagaatcaatggagaaaagcagtgaggctgtgaacattcggacctccttactcaacctggtggacttagcaggat
ctgagaggcaaaaagacacccatgcagaagggatgaggttgaaggaggcaggtaacataaaccgatcactgagctgcctgggcc
aagtcatcactgcccttgttgatgtgggcaatgggaaacagaggcatgtctgctaccgggactccaaacttaccttcttacttcgggact
cccttggtggcaatgccaaaacagccataattgcaaatgttcatccaggatccaggtgttttggggaaacactgtcaacacttaattttgc
tcaaagagccaagctgattaaaaacaaggctgtggtaaatgaagacacccaaggaaatgtgagccagctac 
 
aagctgaagtgaagagactcagagaacaactgtctcagtttacgtctgggcagctgacaccaggaagctcattggccagagataa
agagaaggctaattacatggaatatttcctggaagcaatgttattctttaagaaatctgaacaggaaaagaagtctctagtagaaaaaatt
acccaactagaagacctcaccctcaaaaaggaaaaatttattcagtctaataaaatgattgtgaagttccgagaggaccaaatcatgcg
tctggaaaggcgccagaaggaggcgcgaggaagcttcctgccggaggagcaggatcgcctgctgtcagaactgagggatgagat
ccggacgcttcgagagcaagtggagcaccatcccagactcgcgaagtatgctatggagaatcattccctcagggaagagaatagaa
aactgaaattattagcacctgtgaaaagagcccatgaactcgatgcccaggctattgctcgactagaacaggctttttctgaagtgtcta
gtacagagacaaatgacataggtctgcaaggacttcctcccaaagcaataaaagaaccaagtttcttcacaagcaccgagaagttaaa
agtacaactcctgcaaattcagacagagctgaataattcaaagcaagagtatgaagagttcaaagagttaactcggaagaagcagcta
gaattagaatcagagcttcagtccttgcaaaaagcaaacctcaatcttgaaaaccttttggaggcaacaaaagtctgcaaacgccagg
aagtttctcagctgaataaaatacatgctgaaacactcaagataattaccactccaaccaaggcttatcagctttgttctagactagtacca
aagtcaagccctgaggtggggagctttggcttcctgcgctcacagagtgctccagataatgatatattgaatgagccagtgccacctg
agatgagtgaacaagctctggaggccatttctgaggagcttcgaactgtgcaggaacaactgagtgttcttcaagtcaag 
 
 
 
 
MOTOR F 
MOTOR R 
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Table 1.2: Full sequence of Kif15 and its functional domains (continue) 
 
 
 
ctggatgaagaagaacataaaaacctgaaacttcaacagaatgttgacagactagaacaccattctacacaaatgcaggagctgtt
ctcatcagaaagaagcgattggagcaaacaacagcaggactacctcacacagctcagcgaccttgagaagcagctccaggatgcg
cagactaagaatgactttttgaaatgtgaggtacatgacctgcgaattgttcttaattctgctgacaaagaactttctttggtgaaactgga
gtatagcacattcaaagagagtcaagagaaagaactaagccagctttctgacagacatgtgcaggttcagcttcagctggacaatgcc
agattagaaaatgaaaaacttcttgagagccaagcctgtctacaggattcctacgataacttacaagaagtaatgaaattcgaagttgac
caactttcaaaaaacctccaaaactgcaaacaagagaatgaaactttaaagtctgatctgcataacttggtggagctttttgaggcagaa
aaagagcgcaacaacaaattgtcactacagtttgaagaagataaagaaaacagctctaaagaaatcttaaaggctcttgaaactgtac
gtcaggaaaaacaggaagagatggccagatgtgaaaagcagatggcaaaggtacaggaactagaagaaagcttgcttgctgctga
aaatgttgtcagctgtctggagaagtctagggagtctgacaaggaacttgtcaccaacctcatgaaccaaatccaggagttaagaacat
cagctggtgaaaaatcagaagccatagacaccctgaaacaagagctgcaagacataagttgcaaatacactgctgctgtggctgaca
aagaagagagcaaggagttgatcaggagacaggaagtggatatcctggaactgaaagaaactcttagactgagaattctctcagag
gacatcgagagggatatgctgtgtgaagatctggcccatgccactgagcagctgaacatgctcacagaggcctccaaaaagcactct
ggactactgcagtctgcccaggaagagctgaccaagaaggaggctctgatccaggaacttcagcacaagt 
 
taaaccaggagaaggaggaagtggagcagaagaagagtgagtacaacttgaagatgaagcagctggagcacgtgatgggctct
gctcctgagtatccacagagtccaaaaacaccaccccattttcaaactcatttggcaaaactcttggaaacacaagaacaagagatag
aagacggaagggcatctaagatgtctttgcaacacctcgtcacaaagctaaacgaagacagagaagtcaaaaacgctgagatcctca
ggatgaaggatcagttgtgtgaaatggaaaatctgcgcctggagtctcagcagttgagagagagaacctggctcctgcagactcagc
tggatgatatgaagaggcagggggagagcagcagtcagagtcgtccagacagccaacagctgaagaatgaatatgaagaggaga
ttatcagagagagacttgctaaaaataaacttattgaagaaatgctaaaaatgaaaacagatctagaggaagtccagagtgcacttgac
agcaaggagaagttctgccacagaatgagcgaggaagttgagcgaaccagaactttggagtccagagcatttcaggaaaaggagc
aattgcggtcaaagttggaagaaatgtatgaagagagagagagaacttgccaggaaatggaaatgctgagaaaacaactagagtttc
ttgctgaggaaaatgggaaattgataggtcatcaaaacctacatcagaagattcaatatgtagtgcgactgaagaaggaaaatatcag
gcttgctgaggagacagaaaaattgcgtgctgaaaatgtatttttgaaagaaaggaaaaaagaatga 
 
nnn: motordomain: 1139 
nnn: taildomain: 790bp 
nnn: myosin tail homology domain.1897bp 
 
 
 
MYO R 
TAIL F 
TAIL R 
MYO F 
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MATERIALS AND METHODS 
2.1. Materials 
2.1.1. Lab Equipments 
The following epuipments mentioned in the table 2.1. were used during the project 
Table 2.1: Laboratory equipments used in project 
Centrifuges Beckman coulter, Avanti J-30I, Microfuge 18, Beckman Coulter, 
Memmert, Sigma Biolab 6K15 
Centrifuge rotors MLA 80, Beckman Coulter, JLA-16250, Beckman Coulter, 70Ti, 
Beckman Coulter, TS-5.1-500, Beckamn Coulter 
DNA sequencer Applied Biosciences 3100-Avant 
Autoclave 2540 ML benchtop autoclave, Systec GmbH Labor-
Systemtechnik. NuveOT 4060 Vertical Steam Sterilizer, Nuve 
Magnetic stirrer Labworld Standard Unit 
Transilluminator Biolab 
PCR machines Applied Biosystems, Gene AmpR, PCR system 2700 Techne TC- 
412/ TC-312 
Deep freezes and 
refrigerators 
Heto Polar Bear 4410 ultra freezer, JOUAN, Nordic A/S, catalog# 
003431, 2031 Deep freezer, Arçelik, Deep freezer, Uğur, 1061 M 
refrigerator, Arçelik 
Vortexing machine Reax Top, product# 541-10000, Heidolph2.2 
Shaker Certomat R SII B-Braun Biotech International 
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Table 2.2: Laboratory equipments used in Project continue 
Incubator EN400, Nüve 
Microwave MD582, Arçelik 
Electrophoresis 
equipments 
EC 120 Mini Vertical Gel System, Thermo EC 
Power supply EC 250- 90, E-C Apparatus 
Ice machine AF 10, Scotsman 
pH meter MP 220, Metler Toledo International Inc,  Inolab pH level 1, 
order# 1A10-1113, Wissenchaftlich-Technische Werkstätten, 
GmbH & Co KG 
Balances Precise BJ 610C, order# 160-9423-050, Presice Instruments AG 
Dietikon 
Pipettes 0.1-2.5 µl, 500-5000 µl, Mettler Toledo,10 µl, 20 µl, 200 µl, 1000 
µl, Gilson 
Pipette tips 1-1000 µl, 1-200 µl, Axygen, 1-10 µl, Molecular Bioproducts 
Laminar flow cabinet Ozge 
Pure water systems USF Elga UHQ-PS-MK3, Elga Labwater 
Spectrophotometers DU530 Life Science UV/Vis, Beckman, UV-1601, Shimadzu. 
Corporation, Lambda 25 UV/Vis, Perkin Elmer 
Spectrophotometer 
cuvettes 
Delta 
Test tubes 1.5 ml tubes, Eppendorf 
Water bath Memmert 
Gel documentation 
system 
UVIpro GAS7000, UVItech Limited 
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2.1.2 Chemicals and enzymes 
Chemicals and enzymes mentioned in table 2.3. were used during the project 
Table 2.3: Chemicals and enzymes 
EcoRI restriction enzyme 
SmaI restriction enzyme 
KpnI restriction enzyme 
PstI restriction enzyme  
MassRuler™ DNA Ladder (Mix,  80bp-10Kb) 
Fast Ruler High Range DNA Ladder 
Fast Ruler Middle Range DNA Ladder 
10 mM dNTP mix 
Taq DNA polymerase 
10 X Taq DNA polymerase Buffer (with MgCl2) 
10 X Taq DNA polymerase Buffer (without MgCl2) 
10X Y+ Tango buffer 
PEG 4000 
T4 DNA Ligase Buffer 
T4 Ligase 
 
 
 
 
 
Fermentas 
Control mouse beta actin primer pair   BD 
pEGFP-C1 vector 
pEGFP-C2 vector 
 
Clonthech 
M13 Forward Primer 
M13 Reverse Primer 
 
Invitrogen 
6X Loading dye 
Benchtop 1kb DNA ladder 
 
Promega 
Tryptone 
Yeast Extract 
 
LABM 
IPTG 
Ampicillin 
Kanamycin 
XGal 
 
 
Sigma 
PIPES BDH Biochemical 
KCl 
MgSO4    
NaCl2 
 
Riedel-deHaen 
 
Glycerol         Carlo Erba Reagenti 
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2.1.3 Buffers 
2.1.3.1. TAE Buffer (50x) 
50x TAE buffer stock was prepared by using the content and amount which was 
mentioned in table 2.4. During the agarose gel electrophoresis 1x TAE buffer was 
used bu diluting the 50x buffer stock. 
Table 2.4: Preparation of 50x TAE buffer 
Content Amount 
Tris base (40 mM) 242 g 
Glacial acetic acid (20mM) 57.1 ml 
0.5M EDTA (pH 8.0) (1mM) 100 ml 
H2O up to 1 ml 
2.1.3.2. Buffers of restriction and ligation enzymes 
Buffers of restriction and ligation enzymes were purchased together with the 
enzymes. Suitable buffers were selected according to the recommendation of  
Fermentas Double Digest web page. (www.fermentas.com/doubledigest/index.html) 
2.1.3.3. 10x MOPS Buffer 
10x MOPS buffer was prepared by using the chemicals below in table 2.5. 
Table 2.5: Preparation of MOPS buffer 
Content Final concentration 
MOPS 0.2 M 
Sodium acetate 50 mM 
EDTA 5 mM 
 29 
Note: The buffer is adjusted to pH 7.0 with 1M NaOH and sterilized by autoclaving. 
2.1.3.4. RNA denaturing buffer 
RNA denaturing buffer was prepared by following the constructions mentioned in 
table 2.6. in order to be used in RNA electrophoresis. 
Table 2.6: Preparation of the RNA denaturing buffer 
Content Amount 
100% deionized formamide 10ml 
40% formaldehyde 3.5ml  
10x MOPS buffer 1.5ml  
2.1.4 Special reagents and kits 
Reagents and kits (see table 2.7.) were used for RNA isolation, cDNA synthesis, gel 
extraction, TA cloning, plasmid isolation respectively during the study. 
Table 2.7: Special reagents and kits used in project 
Pure RNA Tissue Kit, Roche 
RevertAid ™ H Minus First Strand cDNA Synthesis Kit, Fermentas 
Agarose Gel DNA  Extraction Kit, Roche and Qiagen 
InsTATM PCR Cloning Kit, Fermentas 
High Pure Plasmid Isolation Kit for small-scale (mini) preparations, Roche 
2.1.5 Bacterial strains 
Escherichia coli (E.coli) strain XL1 Blue [recA1 endA1 gyrA96 thi-1 hsdR17 
supE44relA1 lac [F' proAB lacIqZ∆M15 Tn10 (Tetr)]], Novagen 
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2.1.6 Bacterial Culture Media 
2.1.6.1. Preparation of LB and LB-Agar Plates 
For preparing 1 L of LB, following contents (see table 2.8.) were measured and 
resolved in dH2O, after completeing the volume to 1 L, mixture was autoclaved for 
15 minutes (min.). This LB was used for overnight growth of the bacteria (overnight 
culture) with including related antibiotic.    
                                                     Table 2.8: LB media contents 
Content Volume-gram (g)/L 
Tryptone 10 
Yeast Extract 5 
NaCl 10 
For preparing LB-Agar plates with antibiotics, LB medium was prepared as 
mentioned above, in addition to this mixture, 15 g agar for 1 L was added and after 
mixing with stirrer it was autoclaved for 15 min. Before pouring the plates, the bottle 
which contains the LB-agar was cooled enough to hold by hand, related antibiotic 
was added (1µl /1ml), then he plates were poured and stored at 4o C. 
2.1.6.2. Preparation of SOC Medium 
SOC medium was used to cultivate E.coli for 1 hour after temperature shock during 
transformation. Following contents (see table 2.9.) were measured and distilled water 
was added to a final volume of 100 ml, and it was sterilized by autocaving at 120°C 
for 15 min.                       
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Table 2.9: Content of  SOC medium 
 
 
 
 
 
 
 
2.1.6.3. Preparation of Ampicillin and Kanamycin Stocks 
For preparing ampicillin or kanamycine stocks (100 µg/ml), 1gr from kan/amp was 
taken and resolved in 10 ml dH2O, after fitler sterilization they were aliquoted and 
kept at -20o C. 
2.1.7. Preparation of IPTG/Xgal 
IPTG/Xgal was used in the last step of transformation which was performed 
following the TA cloning ligation, in order to determine the colonies carrying the 
desired inserts. 
1.25 g of IPTG and 1g of XGal were measured and di-methly-formamide was added 
to a final volume of 25 ml. IPTG/XGal was aliquoted and kept at -20o C. 
2.1.8. TA Cloning vector 
pRZ57R/T cloning vector provided by InsTATM PCR Cloning Kit, Fermentas  was 
used as a cloning vector. (see figure 2.1.) 
Content  Amount,g 
Tryptone 2 
Yeast Extract 5 
NaCl2 0.058 
KCl 0.0186 
MgCl2 0.095 
MgSO4 0.024 
Glucose 0.36 
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Figure 2.1: Vector map of pTZ5R/T cloning vector. Source:www.fermentas.com 
2.1.9 Expression vectors 
pEGFP-C1 and pEGFP-C2 were used as expression vectors. (see Figure 2.2 and 2.3.) 
 
Figure 2.2: Vector map of pEGFP-C1. Source: www.fermentas.com 
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Figure 2.3: Vector map of pEGFP-C2. Source: www.fermentas.com 
2.2 METHODS 
2.2.1 RNA Isolation 
RNA isolation was performed using Roche, High Pure RNA Tissue Kit. The 
principle of this isolation is as follows: As a prerequisite for the reverse transcription 
polymerase chain reaction (RT-PCR), intact RNA must be isolated from tissue. 
Tissue samples are homogenized in the presence of a strong denaturing buffer to 
inactivate RNases and to ensure the isolation of intact RNA. After the addition of 
ethanol, RNA binds selectively to a glass fiber fleece in the presence of chaotropic 
salts. Residual contaminating DNA is digested by DNaseI and applied directly on the 
glass fiber fleece. The binding process is specific for nucleic acids, which are 
purified from salts, proteins, and cellular components by repeated washing and 
centrifugation steps. The bound RNA is eluted in water.  
The protocol is as followed: 
- Adult rat was sacrificed and brain was taken out by using fine forceps. 
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- Amounts of lysis/binding buffer was chosen according to the disruption and 
homogenization method,  400 µl lysis/binding buffer was added into a nuclease-free 
1.5 ml microcentrifuge tube containing the tissue.  
- Disruption and homogenization was performed with the help of a nuclease-free 
stick. In order to obtain an optimum and homogeneous mixture, this lysate was 
passed 30 times through a gauge needle fitted to a syringe. 
- Lysate was centrifued for 2 min. at maximum speed in a microcentrifuge and only 
the collected supernatant was used for subsequent steps.  
- 200 µl (0.5 volumes) absolute ethanol was added to the lysate supernatant and 
mixed well.  
- The high pure filter tube was combined with the collection tube and the entire 
sample was pipetted in the upper reservoir (maximal volume 700 µl). 
- The tube was centrifuged 30 seconds (sec.). at maximal speed (13, 000 × g) in a 
standard table top microcentrifuge. 
- After this centrifugation step, dryness of the glass fleece was checked. Since it must 
be dry; if it looked wet, the centrifugation time must have been increased. 
- The filter tube was removed from the collection tube, and the flowthrough liquid 
was discarded. The filter tube was recombined with the used collection tube. 
- For each isolation, 90 µl DNase incubation buffer was put into a sterile 1.5 ml 
reaction tube, and 10 µl DNase I working solution was added and mixed. This 
solution was pippeted to the upper reservoir of the filter tube and incubated for 1 
hour at room temperature. 
- 500 µl wash buffer I was added to the upper reservoir of the filter tube and 
centrifuged 15 s at 8,000 × g. 
- The filter tube was removed from the collection tube and the flowthrough liquid 
was discarded. The filter tube was combined with the used collection tube again. 
- 500 µl wash buffer II was added to the upper reservoir of the filter tube and 
centrifuged 15 s at 8,000 × g the flowthrough was discarded. 
- The filter tube combined with the used collection tube. 
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- 300 µl wash buffer II was added to the upper reservoir of the filter tube and 
centrifuged 2 min at full speed (approx 13, 000 × g). 
- The column was removed carefully from the collection tube in order to prevent the 
any possible contact of the column with the flowthrough which will result in 
carryover of ethanol. 
- The filter tube was inserted into a nuclease free, sterile 1.5 ml microcentrifuge tube. 
- 100 µl elution buffer was added to the upper reservoir of the filter tube and the tube 
was centrifuged for 1 min at 8,000 × g. 
 Note: This step was repeated (double elution was performed) in order to obtain 
denser RNA. 
- Isolated RNA was aliquoted into nuclease free, sterile 0.6 ml microcentrifuge tubes 
and stored at -80°C for later analysis. 
Note: Gloves were changed frequently during the experiment and all steps were 
performed on ice. 
2.2.2 Agarose-Formaldehyde electrophoresis for RNA 
RNA electrophoresis under denaturing conditions in 2.2 M formaldehyde is 
performed according to Maniatis et al., (1982) using MOPS buffer system. RNA 
under these conditions is fully denatured and migrates according to the log10 of its 
molecular weight. 
In order to check if the RNA isolation was performed successfully, 1% agarose-
formaldehyde gel was prepared as follows: 
0.5 g of agarose was melted in 37 ml H2O, it was cooled to the hand hot. Then, 5ml 
10x MOPS buffer and 8.75 ml 40% formaldehyde was added. 
The sample RNA was prepared by adding up to 25 mg of RNA in a maximum of 5 µl 
sterile H2O, to 15 µl of RNA denaturation buffer. 1µl 10mg/ml ethidium bromide 
was added to help visualization of RNA after electrophoresis. Electrophoresis was 
performed with 1x  MOPS. The sample was placed into a well on the agarose gel and 
the gel was run at 70 mV for 30 min. 
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RNA within agarose gels are only visible when stained with ethidium bromide and 
can then be visualized under UV light. The gel was placed onto an UV illuminator 
that emits UV light at 302 nm and photographed with a camera connected to a 
computer. Image files were saved with UVIPhotoMW Version 99.05 for Windows 
95 & 98, UVItec Ltd. and subsequently analyzed. 
Note: Since formaldehyde is extremely toxic, gloves were used while handling. 
2.2.3 cDNA Synthesis 
To obtain cDNA from the RNA that we isolated, Fermentas, RevertAid ™ H Minus 
First Strand cDNA Synthesis Kit was used. By using this kit, first strand cDNA was 
synthesized from our adult rat total RNA. The Kit uses RevertAid™ H Minus M-
MuLV Reverse Transcriptase which, due to the lack of RNaseH activity, does not 
degrade RNA in DNA-RNA hybrids during the first strand cDNA synthesis.  This 
allows more RNA templates to be completely reverse transcribed into total cDNAs. 
The cDNA, synthesized by using this system, can be used as a template in the 
polymerase chain reaction (PCR) or it can be used as a template for second strand 
synthesis. In this experiment, we used it for the first purpose: 
 
- The following reaction mixture mentioned in table 2.10. was prepared in a tube 
on ice: 
Table 2.10: cDNA synthesis reaction 
Content Concentration Amount 
template RNA (total RNA)                          10 ng-5 µg 10µl 
primer (oligo(dT)18 primer)           (0.5 µg/µl)  1µl 
DEPC-treated water            -                                    1µl 
Total reaction mixture 12µl 
 
- The mixture was gently mixed and spined down for 3-5sec. in a 
microcentrifuge. 
- The mixture was incubated at 70°C for 5 min, then chilled on ice and the drops 
were collected by brief centrifugation. 
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- The tube was placed on ice and the following components mentioned in table 
2.11. were added in it in the indicated order 
Table 2.11: cDNA synthesis reaction continue 
5x reaction buffer 4µl 
RiboLock™ Ribonuclease Inhibitor (20u/µl) 1µl 
10mM dNTP mix 2µl 
 
- The mixture was mixed gently and drops were collected by brief centrifugation. 
- The mixture was incubated at 37°C for 5min  
- Add RevertAid™ H Minus M-MuLV Reverse Transcriptase (200u/µl) was 
added (1µl) .Then the final volume would be 20µl. 
- The mixture was incubated at 42°C for 60min  
- The reaction was stopped by heating at 70°C for 10min.  
- cDNA was stored at -20°C 
After cDNA synthesis, PCR reactions were set in order to check if we successfully 
performed the cDNA synthesis process. By using the beta-actin commercial primers, 
different concentrations of the cDNA obtained was tried to determine the optimum 
amount of cDNA which will be used in further steps. 
2.2.4 Primer Design: 
In order to clone desired domains of Kif 15, seven primers were designed for motor 
domain, myosin tail homology domain and tail domain respectively. During primer 
synthesis followings were considered: 
- Melting temperatures of the primers were selected as close as possible in order 
to facilitate the optimum annealing temperature selection.  
- GC content of the primers were taken into consideration and primers that have 
GC content more than 60% were not chosen.  
- Melting temperature, hairpin and self dimer formation were checked by using 
IDT Scitools oligo analyzer.  
            (www.idtdna.com/analyser/Applications/OligoAnalyzer) 
Although some hairpin and self dimer formations were observed, the sequences 
where primers will be synthesized were chosen as suitable as possible by considering 
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the points above. Primers synthesized by considering these points were mentioned in 
table 2.12. 
Table 2.12: Kif15 sequence specific primers list 
 
2.2.5 PCR 
The polymerase chain reaction is a technique for quickly "cloning" a particular piece 
of DNA in the test tube. So, unlimited copies of a single DNA molecule can be 
amplified bu using this technique. After deciding the primers which restricts the 
sequence we want to amplify, related components were added and some different 
PCR programs were performed. For initial denaturation, where two strands of DNA 
were separated, 94°C was used. Same temperature was used for also denaturation 
step. Annealing temperatures, where primers bind to the complementary regions of 
the DNA, were changed according to the primers melting temperatures used. Finally, 
elongation and final elongation steps where suitable bases are arranged in an order, 
72°C was used. 
PCR reactions were performed by using the cDNA which synthesized from adult rat 
brain and primers designed as mentioned before. 25 µl total reactions were prepared. 
PCR conditions (see table 2.13, 2.15, 2.17.)) and programs (see table 2.14, 
2.16,2.18.) by which desired results were obtained are as followed.  
 
 
 
 
 
 
Primer 
 
Sequence Lenght Tm°C Location 
(bp) 
MotorF CAGCCAAGTAACGAAGATGATG 22 62 55 
MotorR CTGCCCAGACGTAAACTGAGAC 22 66 1194 
Myo F CTTCAACAGAATGTTGACAGACTAGAACAC 30 64.6 2227 
Myo R CGCAATTTTTCTGTCTCCTCAG 22 65 4121 
Tail F TGGAGCACTGATGGGCTCTGCTCCTGAG 28 71.7 3382 
Tail R TCATTCTTTTTTCCTTTCTTTCAAAAATACATTTTCATCA 40 69.1 4192 
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10 cycles 
each 
Table 2.13: PCR reaction set up for motor domain 
 
 
 
 
 
 
 
 
 
Table 2.14:  PCR run program for motor domain 
Initial Denaturation 94 1 min.  
Denaturation 94 30 sec. 94 30 sec. 94 30 sec. 94 30 sec. 94 30 sec. 
Annealing 54 1 min. 55 1 min. 56 1 min 57 1 min. 58 1 min. 
Elongation 72 2 min. 72 2 min 72 2 min 72 2 min. 72 2 min. 
Final Elongation 72 10 min.  
Note: All values are °C. 
Table 2.15: PCR reaction set up for myosin tail homology domain 
Content Amount 
Template (adult rat cDNA- 3.96µg/ml) 0.5 µl 
Myo F (25µg/ml) 0.5 µl 
Myo R (25µg/ml) 0.5 µl 
dNTP mix (10 mM each) 0.5 µl 
10X Taq Buffer 2.5 µl 
Taq DNA Polymerase 0.5 µl 
H2O 20 µl 
Total reaction: 25 µl 
                          
 
 
 
 
Content Amount 
Template (Motor DNA after gel Extraction) 0.5 µl 
Primer-1: Motor F (25µg/ml) 0.5 µl 
Primer-2: Motor R (25µg/ml) 0.5 µl 
dNTP mix (10 mM each) 0.5 µl 
10X Taq Buffer 2.5 µl 
Taq DNA Polymerase (5u/µl) 1µl 
H2O 19.5 µl 
Total reaction: 25µl 
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Table 2.16: PCR run program used for myosin tail homology domain 
 
 
 
 
 
 
                                         Table 2.17: PCR reaction setup for tail domain 
 
 
 
 
 
 
 
 
 
 
Table 2.18: PCR run program used for tail domain 
 
 
 
 
 
 
2.2.6 Agarose gel electrophoresis 
Agarose gel electrophoresis is the most commonly used system which is employed to 
check the progression of a restriction enzyme digestion, to quickly determine the 
yield and purity of a DNA isolation or PCR reaction, and to size fractionate DNA 
molecules, which then could be eluted from the gel. The principle in agarose gel is 
the migration of negatively charged DNA, by electric current through a matrix of 
agarose. Since small molecules migrate faster than large ones, it will be possible to 
Initial Denaturation 94°C 30 sec 
Denaturation 94°C 1 min 
Annealing 55°C 1 min 
Elongation 72°C 2 min 
Final Elongation 72°C 5min 
 
 
40 cycles 
Content Amount 
Template (adult rat cDNA- 3.96µg/ml)  0.5µl 
Tail F (25µg/ml) 0.5µl 
Tail R (25µg/ml) 0.5µl 
dNTP mix (10 mM each)-Qiagen 0.5µl 
10X Taq Buffer-Roche 2.5µl 
Taq DNA Polymerase-Roche 1µl 
H2O 19.5µl 
Total reaction: 25µl 
Initial Denaturation 94°C 30 sec 
Denaturation 94°C 1 min 
Annealing 60°C 1 min 
Elongation 72°C 2 min 
Final Elongation 72°C 5min 
 
 
40 cycles 
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get information about DNA in the cases indicated above. In this project, 1% low 
melting agarose gels were used.  
To prepare 1% agarose gel, 0.4 g of low melting point: 
- Agarose was dissolved in 40 ml (small gel) 1x TAE (Tris-acetate-EDTA) 
buffer.  
- The agarose was solubilized in a microwave oven until the agarose was 
completely dissolved. 
- Gel was cooled to ≤ 45ºC and ethidium bromide was added to a final 
concentration of 0.5 µg/ml and mixed through gentle swirling.  
- The agarose gel was then poured into a horizontal gel tray, and a comb for 
forming the sample slots was placed into the gel.  
- The gel was solidified for about 20 min. and then placed into an electrophoresis 
tank, where the gel was covered by 1x TAE buffer used to make the gel. 
The DNA was mixed with loading dye  and the sample was placed into a well on the 
agarose gel. As fragment size control, suitable marker which was selected according 
to the expected DNA fragment size, was used. Electrophoretic separation was 
performed by constant current at 100 mV for 20-30 min. 
DNA and RNA fragments were visualized by staining with ethidium bromide. This 
fluorescent dye intercalates between bases of DNA and RNA. It is often incorporated 
into the gel so that staining occurs during electrophoresis and can then be visualized 
under UV light, or the gel can also be stained after electrophoresis by soaking in a 
dilute solution of ethidium bromide. So,  the gel was placed onto an UV illuminator 
that emits UV light at 302 nm and photographed with a camera connected to a 
computer. Image files were saved with UVIPhotoMW Version 99.05 for Windows 
95 & 98, UVItec Ltd. and analyzed. The size of the DNA was determined by 
comparing fragments formed the suitable DNA marker.  
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2.2.7 Gel Extraction  
For isolation of  DNA fragments from agarose gel, Qiagen MinElute Gel Extraction 
which is designed to purify  DNA of  70 bp to 4 kb from standard or low-melt 
agarose gels in TAE or TBE buffer was used. Gel extraction is necessary for 
isolating DNA after PCR reactions and restriction reactions in cloning process. Since 
DNA is extracted from agarose gel, it should be cut as thin as possible in order to 
obtain DNA in sufficient concentration. Following steps were followed for extraction 
of DNA from 1% agarose gel: 
- DNA fragment was excised from the agarose gel with a clean, sharp scalpel. 
The size of the gel slice was minimized by removing extra agarose. 
- The gel slice in a colorless tube was weighed. 3 volumes of Buffer QG to 1 
volume of gel (100 mg ~ 100 µl) was added. 
- Tube was incubated at 50°C for 10 min. To help dissolve gel, tube was  mixed  
by inverting in every 2–3 min. during the incubation. Finally, gel was solubilized 
completely and the colour of the mixture was checked.  
- After the gel slice has dissolved completely, the color of the mixture was 
checked (it should be like QG buffer color). 
- 1 gel volume of isopropanol was added to the sample and mixed by inverting 
the tube several times. 
- A MinElute column was placed in a provided 2 ml collection tube in a suitable 
rack. 
- To bind DNA, the sample was applied to the MinElute column and centrifuged 
for 1 min. at 14.000 rpm. 
- The flow-through was discarded and the MinElute column was placed back in 
the same collection tube. 
- 500 µl of Buffer QG was applied to the spin column and centrifuged for 1 min. 
at 14.000 rpm. 
- The flow-through was discarded and the MinElute column was placed back in 
the same collection tube. 
- To wash, 750 µl of Buffer PE was added to the MinElute column and 
centrifuged for 1 min at 14.000 rpm. This step was carried out twice. 
- The flow-through was discarded and the MinElute column was centrifuged for 
an additional 2 min. at 14.000 rpm. 
 43 
- The MinElute column was placed into a clean 1.5 ml microcentrifuge tube. 
- To elute DNA, double elution was performed by adding  50 µl of Buffer EB (10 
mM Tris·Cl, pH 8.5) to the center of the membrane,  and then centrifuged for 1 
min at 14.000 rpm.  
      Note: In some cases, 30 µl of EB was used in order to have more    
      concentrated DNA. 
2.2.8 TA cloning 
TA cloning is used for cloning of  PCR products with 3’-dA overhangs into cloning 
vectors which are previously cut and ready to use. InsTATM PCR Cloning Kit, 
Fermentas was used for TA cloning. In order to put PCR products into cloning vector 
pTZ57R/T, first ligation reaction was set considering the manifacturer’s 
recommendations. Recommended amounts were reduced in order to extend the kit’s 
usage period. 
Ligation reactions were set both for motor and tail domains as follows: 
2.2.8.1. Ligation For TA Cloning 
Following ligation reactions mentioned in table 2.19 were used for both motor and 
tail domains: 
                                  Table 2.19: Ligation reaction for TA cloning 
Content Amount 
Plasmid Vector (pTZ57R/T)-0.165µg 1.5 µl 
PCR fragment (Motor-Tail) 8 µl 
10X ligation Bufer 1.5 µl 
10X PEG 4000 1.5 µl 
T4 DNA Ligase (5u/µl) 0.5 µl 
H2O 2µl 
Total Reaction: 15 µl 
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2.2.8.2. Transformation for TA cloning: 
- The competent cells were taken from –80o C and thawed on ice. 2-3 µl of 
purified plasmid DNA or 15 µl of ligation mixture  was added to 25 µl of 
competent cells and the eppendorf tube containing the cells was  incubated on ice 
for 30 min.  
- Then, heat shock was done by putting the cells in waterbath at 42oC for 40-45 
sec. and they were then immediately incubated on ice for 2 minutes. 
- 80 µl of SOC medium was added to competent cells and the eppendorf tube was 
vigorously shaked at 37oC for 1 hour.  
- The cells were taken and 20 µl of IPTG/X-Gal solution was added to each tube. 
Then, the cells were spreaded onto LB plate containing ampicillin since the 
pTZ57R/T plasmid has ampicillin resistance. The plates were incubated at 37oC 
overnight. 
- The following day plates were taken from 37oC incubator and  white colonies 
were counted. Plates were kept at 4oC until their reuse. 
- Colonies were streaked into a new ampicillin resistant plate in order to perform 
colony PCR. 
 
In transformation for TA cloning, we used IPTG/X-Gal for blue white screening. The 
principle of this screening method is as folllows. 
The plasmid used (pTZ57R/T here) contains a gene called LacZ.  The LacZ gene 
codes for an enzyme called beta-galactosidase.  This enzyme is made up of two 
fragments, alpha and omega.  When the two fragments are associated they form a 
functional enzyme.  Normally, beta-galactosidase metabolizes galactose producing 
two products, lactose and glucose.  Beta-galactosidase converts other substrates such 
as X-Gal (5-bromo-4-chloro-3-indolyl-[beta]-D-galactopyranoside) into a colored 
product.  X-Gal is a colorless modified galactose sugar, however, when it is 
metabolized by beta-galactosidase the products are a bright blue.  
In order for the gene to be actively transcribed from the DNA and for the enzyme to 
be produced, an activator called IPTG (isopropyl-[beta]-D-thiogalactopyranoside) 
must be added.  Both X-Gal and IPTG are delivered to the bacteria through the 
growth medium (generally a supplemented and enriched bacto-agar blend).  
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Within the LacZ gene there are multiple cloning sites where the plasmid may be cut 
and DNA may be added.  This produces a plasmid with foreign DNA located within 
the LacZ gene.  When transcription of the gene is activated by IPTG the foreign 
DNA that has been inserted is transcribed as well.  When the gene is later translated 
into the enzyme the inserted DNA is translated as well.  Because of its location 
within the enzyme the foreign DNA's translated protein product disrupts activity and 
function of the enzyme.  The disrupted enzyme activity is observed as a white 
bacterial colony.  (If the enzyme is functioning fully each colony is a bright blue 
color.)  Very small inserts of foreign DNA may lead to light blue colonies.  
2.2.9. Colony PCR  
After transformation for TA cloning, by the help of the blue-white screening, white 
colonies which are candidates for carrying desired inserts were chosen. Colony PCR 
was performed to be sure of selecting right colonies which are carrying inserts. Since 
some white colonies that are expected to have insert are sometimes empty, colony 
PCR is essential. 
- 25 µl of sterile H2O was used for each colony which was taken from the replica 
plate by using sterile tips. 
- Tubes which contain water and a piece of colony were incubated at 99 o C for 5 
min. 
- Cells were centrifuged at maximal speed for 1 min(optional) 
-  Following PCRs mentioned in table 2.20. were performed for motor and tail 
domain respectively: 
Table 2.20: Colony PCR reactions for motor and tail domains 
 Motor Domain Tail Domain 
Template+H2O 20.8 µl 20 µl 
dNTP mix 0.5 µl 0.5 µl 
10X PCR buffer 2.5 µl 2.5 µl 
Primer 1 (motor F) 0.5 µl (tail F) 0.5 µl 
Primer 2 (motor R) 0.5 µl (tail R) 0.5 µl 
Taq Polymerase 0.2 µl 1 µl 
Total Reaction 25 µl 25 µl 
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2.2.10. Overnight culture preparation: 
After identification of  the right colonies which contains the inserts by colony PCR, 
these colonies were taken into the 5 ml LB medium containing 5 µl suitable 
antibiotic (ampicillin or kanamycin) which was added  in order to make selection 
media. Then they were incubated  in 37 o C shaker overnight.  
2.2.11. Small scale plasmid DNA preparation (mini-prep) 
Plasmid  preparation was performed using Roche, High Pure Plasmid Isolation Kit 
for small-scale (mini) preparations, following instructions of the manufacturer. The 
principle of this purification is to release plasmid DNA from bacteria by alkaline 
lysis and to remove all the RNA in the lysate by RNase. Then, since the plasmid 
DNA has the ability to  bind selectively to glass fiber fleece in a centrifuge tube in 
the presence of a chaotropic salt (guanidine HCl), DNA remains bound. After 
washing steps performed to remove contaminating bacterial components, low salt 
elution removes the DNA from the glass fiber fleece. 
The protocol of High Pure Plasmid Isolation Kit, Roche  is as follows: 
- Overnight culture was prepared: A single bacterial colony was picked and 
inoculated into 5 ml LB media (with 5 µl of ampicillin) containing Falcon tube, 
and grown overnight with vigorous shaking (200 rpm) at 37ºC.  
- The next day, 2 ml of the culture was put into an eppendorf tube and 
centrifugated for 1 minute at 9000 rpm. The supernatants were  discarded.  
- The bacterial pellet was resuspended in 250 µl of suspension buffer by 
vortexing the eppendorf  tube.  
- To lyse the cells, 250 µl lysis buffer was added (contains NaOH), mixed by 
inverting the tube 6 times and incubated at room temperature for up to 5 min.   
- Lysis was stopped by addition of 350 µl ice-cold binding buffer. Tube was 
again inverted 6 times and incubated on ice for up to 5 min.   
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- The mixture was centrifuged for 10 min. at 14.000 x g and the supernatant was 
transferred to a filter tube. Chromosomal DNA was precipitated with cellular 
debris during centrifugation and this supernatant contains the plasmid DNA.  
- Again centrifugation for 1 minute at maximum speed was performed.  Plasmid 
DNA is bound to the glass fibers pre-packed in the filter tube. Supernatant was 
discarded from the collection tube.  
- To wash the cells, 700 µl of wash buffer was added to the filter tube and 
centrifuged at maximum speed for 1 minute. Supernatant from collection tube 
was discarded. This step was done twice. 
- Tube was centrifuged at 14.000 rpm for additional 2 min. with adding nothing. 
- To elute the DNA, 100 µl elution buffer was added, and the DNA solution was 
obtained by centrifugation for 1 minute at full speed (double elution was done). 
2.2.12 DNA Sequencing  
2.2.12.1. PCR for Sequencing: 
The purpose of the sequencing is to determine the order of the nucleotides of a gene. 
The sequencing method is based on the use of modified nucleotides, so called 2’, 3’-
dideoxy analogs. These special nucleotides lack a hydroxyl residue at the 3’position 
of the deoxyribose. When DNA polymerase adds nucleotides into a DNA chain 
through its 5’ triphosphate groups, the absence of a hydroxyl group on a dideoxy 
analog avoids the formation of a phosphodiester bond with an adjacent nucleotide, 
leading to a stop in elongation. As the concentration of the analogs is very low, 
termination happens just occasionally. With four different analogous nucleotides in 
four separate reactions, numerous fragments corresponding to every base position 
will be synthesized. As fluorescently labelled primers are used, newly synthesized 
DNA fragments are marked and the sequence can be detected by excitation with a 
laser and detection with photodiodes in a sequencing machine.  
The plasmids with inserts were verified by DNA sequencing using Big Dye 
Terminator v 3.1 Cycle Sequencing Kit (Applied Biosystems). The sequence reaction 
was prepared in a sterile PCR tube by adding the compounds shown below (see table 
2.21). Same compounds were used for both motor and tail domains. 
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Table 2.21: PCR set up for sequencing 
Contents Volume, µl 
Big dye reaction mix 2 
5X sequence mixture 2 
Template DNA 1 
Primer M13  0.5 
dH2O 4.5  
Total reaction volume 10 
The sequence reactions were performed using a thermal cycler with the following 
program mentioned in table 2.22. 
Table 2.22:  PCR program for sequencing 
 
 
 
 
 
 
 
2.2.12.2. PCR Purification For Sequencing: 
- PCR tubes were taken and short spin was performed. 
- PCR products were transformed into 1.5 ml eppendorf tubes. 
- 2 µl, 3M NaAC and 50 µl cold ethanol (95%)  was added to each tube and 
incubated on ice for 30 min. 
- Tubes were centrifuged at 14.000 rpm for 20 min. 
- After discarding the supernatant by pipetting, 250 µl cold ethanol (70%) was 
added into each tube and centrifuged at 14.000 rpm for 20 min. 
- After discarding the supernatant with the help of a pipette, tubes were put into a 
95ºC incubator for drying. 
- 20 µl formamide was used for elution. 
 Temperature Time 
Initial Denaturation 95 ºC 5 min. 
Denaturation 95 ºC 45 sec. 
Annealing 55 ºC 45 sec. 
Elongation 60 ºC 4 min. 
Final Elongation 4 ºC - 
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- Tubes were kept at 4ºC till use. 
- Denaturation was performed at 95 for 2-3 min. and samples were put into the 
sequencer.  
2.2.13.  Alignment of sequences 
Nucleotide alignments were made both with BLAST tool, (available at 
http://www.ncbi.nlm.nih.gov/BLAST/) and ClustalW program (available at 
www.ebi.ac.uk/clustalw/ ) in order to compare the sequences we had after 
sequencing with the original sequences. 
 2.2.14. DNA cleavage with restriction endonucleases 
Restriction endonucleases are enzymes that cleave the sugar-phosphate backbone of 
DNA. These enzymes cut both strands of duplex DNA within a stretch of just a few 
bases. A large majority of restriction enzymes have been isolated from bacteria, 
where they appear to serve a host-defense role. The idea is that foreign DNA, for 
example from an infecting virus, will be chopped up and inactivated ("restricted") 
within the bacterium by the restriction enzyme. Restriction endonucleases recognize 
a specific nucleotide sequence, and cut DNA wherever this specific sequence is 
found. Usually the palindromic restriction sites have a length of 4 to 8 base pairs. 
The purified restriction endonucleases are commercially available, and are used to 
generate DNA fragments for cloning experiments. Therefore, restriction 
endonucleases are a major tool in recombinant DNA technology.  
From the data obtained from sequence analyses which were performed for motor and 
tail domain, it was understood that, tail domain had integrated into pTZ57R/T 
cloning vector in right orientation, but motor domain was integrated into cloning 
vector in reverse orientation. Since these domains had to be cloned into GFP 
expression vectors, suitable vectors and enzymes were selected in order to subclone 
these domians into GFP expression vectors considering their orientation. Two 
different restriction conditions were used for two different domains of Kif 15 (motor-
tail). These enzymes were chosen according to the followings: 
- They have to cut both T/A and expression vectors; 
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- Enzyme cutting sites in the vectors should be same for tail domain and they 
should be reverse for motor domain since the orientation of motor domain is 
reverse in the cloning vector. So, the enzyme which cuts 5’ restriction site on T/A 
vector should be in 3’ restriction site on expression vector; 
- Restriction endonucleases should cut the DNA at the most suitable points which 
does not allow shifting of the sequence.  
- Restriction endonucleases should not cut inserts  (motor and tail domians.) 
Considering all these circumstances, pEGFP-C1 was found suitable for motor 
domain and pEGFP-C2 was found suitable for tail domain. 
2.2.14.1. Restriction for motor domain 
Restriction enzymes and contents were selected as shown in the table 2.23. 
Table 2.23: Restriction of pTZ57R/T-Motor domain and pEGFP-C1 with KpnI/PstI 
Contents Volume, µl Contents Volume, µl 
pTZ57R/T-Motor 20 pEGFP-C1 15 
10X Y+ Tango buffer 2.5 10X Y+ Tango buffer 2 
KpnI 1 KpnI 1 
PstI 1 PstI 1 
dH2O 0.5 dH2O 1 
Total reaction  25 Total reaction 20 
Reaction mixtures were put in 37ºC waterbath for 4 hours. 
2.2.14.2. Restriction for tail domain 
Since two different temperatures are suitable for maximum restriction efficiency for 
these two enzymes (30ºC for  SmaI and 37ºC for  EcoRI), following restriction (see 
table 2.24.) mixtures and conditions were used for maximum efficiency. 
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Table 2.24: Restriction of pTZ57R/T-Tail domain and pEGFP-C2 with SmaI/EcoRI 
Content Volume, µl 
pTZ57R/T-Tail 20 
10X Y+ buffer 2.5 
SmaI 1 
dH2O 1.5 
Total Reaction: 25 
 
 
2 hours at 30ºC 
 
                                  
       
 
 
 
2.2.15. Ligation 
Ligation reactions were performed in order to subclone inserts found in cloning 
vectors (pTZ57R/T-Motor, pTZ57R/T-Tail)  into expression vectors (pEGFP-C1 and 
pEGFP-C2). Following the restriction reactions, related domains were gel purified 
and considering the brightness of the fragments observed on gel, their concentrations 
were estimated and ligation reactions were set. 
2.2.15.1. Ligation For Motor Domain: 
Two different ligation conditions were tried as metioned in table 2.25. 
Table 2.25: Ligation reaction for subcloning of motor domain into GFP 
Content 1st condition/volume- µl 2nd condition/volume- µl 
pEGFP-C1 1 3 
Insert-Motor 7 10 
PEG 4000 1 1 
T4 DNA Ligase buffer 1.5 1.5 
T4 DNA Ligase 0.5 0.5 
H2O 4 4 
Total Reaction 15 20 
Content Volume, µl 
10X Y+ buffer 3.5 
EcoRI 1 
dH2O 0.5 
Total Reaction: 30 
 
 
2 hours at 37ºC 
Content Volume, µl 
pEGFP-C2 15 
10X Y+ buffer 2 
SmaI 1 
dH2O 2 
Total Reaction: 20 
 
 
2 hours at 30ºC 
Content Volume, µl 
10X Y+ buffer 3 
EcoRI 1 
dH2O 1 
Total Reaction: 25 
 
 
2 hours at 37ºC 
  Add 
  Add 
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2.2.15.2. Ligation For Tail Domain: 
Two different conditions were tried as mentioned in table 2.26. 
Table 2.26: Ligation reaction for subcloning of tail domain into GFP 
Content 1st condition/volume- µl 2nd condition/volume- µl 
pEGFP-C2 1 3 
Insert-Tail 7 10 
PEG 4000 1.5 2 
T4 DNA Ligase buffer 1.5 2 
T4 DNA Ligase 1 1 
H2O 3 2 
Total Reaction 15 20 
2.2.16. Competent Cell Preparation-CaCl2 Method:  
In order to carry out transformation, competent cells must be used because normal 
E.coli cells are not competent and they do not have the ability to take foreign DNA 
from environment. For this reason, some physiologically healthy cells growing under 
optimal conditions are suddenly chilled and resuspended in a “starvation medium” 
consisting of a dilute solution of calcium chloride. Since cells that are undergoing 
very rapid growth are made competent more easily than cells in other stages of 
growth, they should be taken at this stage. 
 Although the exact mechanism is still somewhat unknown, calcium ions are thought 
to open some hydrophilic channels in the membrane and disrupting the cell wall 
integrity of bacteria, which allows the passage of the DNA. When these competent 
cells are mixed with plasmid DNA, the DNA attaches to the exposed portions of the 
cell membrane. If a “heat shock” is given to these cells, the DNA is absorbed into the 
cell's cytoplasm. The transformed cells are then allowed to grow in a rich media like 
LB broth or SOC to allow time for resynthesis of the cell wall and expression of any 
genes on the newly acquired plasmid DNA. Finally, these cells are plated on agar 
plates which only transformed cells can grow on. 
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To introduce plasmid DNA or recombinant plasmid DNA into bacteria, the bacteria 
had to be made competent for this purpose. We homemade competent cells according 
to the following protocol: 
E. Coli - XL1 Blue cells were taken from a glycerol stock culture by scraping with a 
tip and it was directly put in a falcon containing 5ml LB medium and incubated 
overnight at 37°C in a rotatory shaker.  
- The following day,  100 ml LB medium was inoculated with 5 ml of overnight 
culture solution and was incubated at 37°C in a rotatory shaker. Cell density was 
measured several times by a spectrophotometer at OD600 to control if they 
reached approximalety 0,6. When the OD600  reached to 0,56 the bacteria were 
transferred to 50 ml prechilled sterile ultracentrifuge tubes and incubated on ice 
for 10 min. 
- The cells were spun down at 1600 x g for 7 min. at 4ºC, the supernatant was 
discarded. 
- Each bacterial pellet was resuspended in 10 ml ice-cold CaCl2  and centrifuged 
for 5 min. at 1600 x g at 4ºC, the supernatant was discarded. 
- Each bacterial pellet was resuspended in 10 ml ice-cold CaCl2  and they were 
incubated on ice for 30 min. 
- Centrifugation was performed again at 1600 x g  for 5 min. at 4ºC  
- Each pellet was resuspended completeley in 2 ml of CaCl2.  
-  The competent cells were distributed into prechilled sterile microfuge tubes 
each contains 40 µl and they were stored at – 80ºC. 
     For 50 ml CaCl2 solution following contents with mentioned concentrations and 
amounts in table 2.27. were used. 
Table 2.27: CaCl2 Solution Preparation: 
Contents Concentration Amount 
CaCl2 60 mM 0.33 g 
PIPES 10mM 0.15 g 
Glycerol 15% 7.5 ml 
H2O X up to 50 ml 
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2.2.17. Transformation of competent cells 
Transformation is the term used to describe the introduction of plasmid DNA into 
bacteria. As mentioned above, competent cells were used for transformation. 
Although transformation can be performed by an electrical or a chemical method, we 
used the chemical method which consists of a heat shock to introduce the DNA into 
the host as follows; 
- The competent cells were taken from –80oC and thawed on ice. 2-3 µl of 
purified plasmid DNA or 10-15 µl of ligation mixture  was added to 20-25 µl of 
competent cells and the eppendorf tube containing the cells was  incubated on ice 
for 30 min.  
- Then, heat shock was done by putting the cells in waterbath at 42o C for 40-45 
sec. and they were then immediately incubated on ice for 2 miutes. 
- 80 µl of SOC medium was added to competent cells and the eppendorf tube was 
vigorously shaked at 37o C for 1 hour.  
- The cells were then spreaded onto LB plate containing the appropriate 
antibiotic. The plates were incubated at 37o C overnight. 
2.2.18. Confirmation Restriction 
After transformation, colonies grown on plates was checked by colony PCR to find 
out which colonies were carrying the inserts. The colonies with inserts were 
transfered to 5 ml LB culture with kanamycine. Following day, plasmid preparation 
was carried out for pEGFP-C1/Motor domain and pEGFP-C2/Tail domain. 
Confirmation restriction is another way to confirm the plasmid if it has the insert or 
not. For this reason, couple of enzymes, usually the enzymes used for restriction 
reaction, are used. Therefore, we expect two clear fragments of vector alone and 
insert. 
Confirmation reaction was carried out with the same enzymes which were used for 
digesting the desired domains from pTZ57R/T vector and expression vectors. 
Following conditions (shown in table 2.28 and 2.29.) were used: 
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Table 2.28: Confirmation restriction for motor domain 
 
                                                     
 
 
 
 
 
 
Table 2.29: Confirmation restriction for tail domain 
Content Volume- µl 
pEGFP-C1/Tail domain 5 
SmaI 0.5 
10 X Y+ Tango Buffer 1 
dH2O 3.5 
                                                                 
2.2.19. Glycerol Stock Preparation: 
In order to keep our constructs safely for long time to use in further studies, glycerol 
stocks have to be made. Glycerol is used  in order to minimize the damage which can 
be revealed during freezing and thawing of the cells. Four glycerol stocks, (final 
concentration of 20%), were prepared for plasmids which are carrying desired 
domains.(pTZ57R/T-Motor, pTZ57R/T-Tail, pEGFP-C1/Motor, pEGFP-C2/Tail). 
For this purpose; 
800 µl cells (XL1 Blue, carrying related plasmid with desired insert) 
200 µl glycerol (100%) were mixed together and kept at -80o C 
 
 
 
Content Volume- µl 
pEGFP-C1/Motor domain 5 
KpnI 0.5 
PstI 0.5 
10 X Y+ Tango Buffer 1 
dH2O 3 
Total reaction  10 
EcoRI 0.5 
10 X Y+ Tango Buffer 2 
dH2O 2.5 
Total reaction 15 
Add 
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2.2.20. Determination of nucleic acid concentration 
Recovery, purity and concentration of nucleic acids were determined by 
spectrophotometric analysis and mostly estimation from the gel.  
The ratio of absorbance at (A260) is used  for DNA. For the measurement, we used a 
spectrophotometer from Shimadzu. The DNA was diluted 1:1000 in distilled water 
and transferred to a quartz cuvette. The absorption was at wavelength of 260 nm. An 
optical density (OD) of 260 nm of 1.0 is equivalent to 50 µg/ml DNA. The formula 
used to calculate the concentration (C) is as follows: 
                           C = OD260 x dilution factor x equivalent = x µg/ml 
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3. RESULTS 
3.1. Adult Rat Brain Dissection  
 
 
Figure 3.1: An adult rat 
An adult rat (see figure 3.1.) was taken under anesthesia by using a piece of cotton 
treated with ethanol. By the help of scissors, skin above the head was cut directly 
from the nape towards the forebrain. The skin was removed gently till the whole 
skull was seen clearly. Since the top of the skull has to be removed in order to reach 
the brain, a scissors tip was used to get just inside then the skull was snipped gently 
by using the tip of  forceps in order to reveal the whole brain. (see figure 3.2.). Then 
the thin membranes (meninges) covering the brain was removed by forceps and brain 
was  very carefully removed from skull cavity by cutting the connections of brain to 
spinal cord and cranial nerves.   
 
Figure 3.2: An adult rat brain and its parts. 
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3.2. RNA isolation from adult rat brain tissue 
Since RNAases are found throughout environment, (hands, laboratory benches, 
distilled water, chemicals), precautions must be taken to avoid problems with 
RNAase contamination. For this reason, RNA isolation was performed in a a highly 
sterile environment where diethyl pyrocarbonate (DEPC) treated instruments and 
RNAase free tips were used during the procedure.  
Since the brain tissue amount needed for RNA isolation procedure is very small (10 
mg maximum according to the High Pure RNA Tissue Kit, Roche) a sterile razor 
blade was used for scrapping the needed amount from the brain and DEPC treated 
plastic sticks, sterile needles were used in homogenization of the brain.  
RNA was eluted by the elution buffer and gel electrophoresis was performed in order 
to see the result of the isolation procedure. 
  
Figure 3.3: Gel electrophoresis result of RNA isolation from adult rat tissue. Arrows indicate the 28S 
rRNA and 18S rRNA 
3.3. cDNA synthesis  
cDNA was synthesized by using Fermentas, RevertAid ™ H Minus First Strand 
cDNA Synthesis Kit. Total RNA isolated from adult rat brain was used as a template 
for this synthesis. Since the cDNAs obtained from this procedure could be used as 
templates in PCR reactions, a control PCR reaction with commercially available 
beta-actin primer was performed in order to check if the cDNA was successfully 
synthesized.   
 
28S rRNA 
18S rRNA 
 59 
 
Figure 3.4: Control of DNA purity by PCR reaction 
It was also important to determine the optimum amount of cDNA which will be used 
in PCR reactions. Thus, cDNA concentration was also calculated by using the 
spectrophotometer as follows:  
Concentration (C) = OD 260nm x dilution factor x constant (33 µg/ml)= X µg/ml 
C= 0.0012x100x33= 3.96 µg/ml 
(Note: 1A260 of ssDNA: 33µg/ml)  
In addition, three different amounts of cDNA were used as templates and the most 
suitable amount was chosen.  
 
Table 3.1: Control PCR reactions after cDNA synthesis 
 
 
 
 
 
 
 
 
 
 *Commercially available mouse beta-actin primer pair, which contains both forward 
and reverse primers and amplifies a 540 bp DNA fragment was used.  
 
 
 
 
Content 
 
1st condition 
 
2nd condition 
 
3rd condition 
Template (adult rat cDNA) 0.2µl 0.5µl 1µl 
Primer: Control mouse ß-actin* 1µl 1µl 1µl 
dNTP mix (10 mM each)- 0.5µl 0.5µl 0.5µl 
10X Taq buffer-Roche 2.5µl 2.5µl 2.5µl 
Taq DNA polymerase-Roche 0.5µl 0.5µl 0.5µl 
H2O 20.3µl 20µl 19.5µl 
Total reaction: 25µl 25µl 25µl 
540 bp 
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  540 bp 
Table 3.2: PCR program used for control PCR reactions after cDNA synthesis 
 
 
 
 
 
 
 
 
                                 
Figure 3.5: Gel electrophoresis showing the PCR results of different concentrations of cDNA 
templates, 0.2µl, 0.5µl, 1µl respectively. 
According to these results, the optimum amount of  beginning template was chosen 
as 0.5µl. 
3.4. Cloning of motor, myosin tail homology and tail domains of Kif15 
3.4.1. PCR for motor domain 
Motor domain was amplified by gradient PCR which was based on gradual increase 
of the annealing tempeatures, from adult rat cDNA. Amounts were used as 
mentioned in the methods section and annealing temperatures were started from 54°C 
and increased 1°C in each 10 cycles till 58°C. 
Initial Denaturation 94°C 1 min 
Denaturation 94°C 30 sec 
Annealing 55°C 1 min 
Elongation 72°C 2 min 
Final Elongation 72°C 5min 
 
 
30 cycles 
1        2          3 
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1139bp 
 
Figure 3.6: 1% gel electrophoresis showing the  result of PCR for motor domain. 
3.4.2. PCR for myosin tail homology domain 
Myosin tail homology domain (myo) which is thought to have an interaction with 
myosin II and is the largest domain of Kif 15 which was  chosen for amplification, 
was successfully amplified  by using a standart PCR program as mentioned in the 
Methods section from cDNA. 
                                                    
Figure 3.7:  PCR results for  myosin tail homology domain 
Following PCRs, DNA fragments were cut out from the gel as clean as possible, 
(avoiding to cut excessive than needed). Gel extraction was performed  using the 
Qiagen MinElute Gel Extraction Kit for motor and myosin tail homology domain. 
After the gel extraction, 1 % agarose gel was used to check the concentration of 
1897bp 
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DNA at the end of the  process.The concentrations was also checked by 
spectrophotometer. 
 
Figure3.8: 1st lane: Gel extraction result for motor domain, 2nd lane: Gel extraction result for myosin 
tail homology domain 
Motor and myosin tail homology domain DNA concentrations was calculated as 
follows: 
 
For motor domain: A260 = 0.006 
C=0.006x1000x50= 300 µg/ml 
For myosin tail homology domain: A260 =0.015 
C=0.015x1000x50= 750 µg/ml 
3.4.3. TA cloning for motor domain 
After amplification of motor domain by gradient PCR, this PCR product was ligated 
into pTZ57R/T cloning vector  using the InsTATM PCR Cloning Kit (Fermentas). 
Suitable conditions were created by following the manufacturer’s recommendations 
as mentioned in the Methods section. Following overnight  room temperature 
ligation, transformation was carried out. By the help of the blue white screening, 
white colonies were picked and they were scanned with colony PCR in order to 
check if they had inserts or not.  Same set of PCR conditions which was used to 
amplify  motor domain from cDNA was used in the colony PCR reaction. 
1897 bp 
1139 bp 
1 2 
2000 
1500 
1031 
C = OD 260nm x dilution factor x constant (50 µg/ml)= X µg/ml 
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Figure 3.9: Colony PCR results for motor domain. PCR products found in lane 1,3,5 and 7 show that 
these colonies contain the insert. 
After confirmation of the presence of the insert in these colonies, 5 ml LB-ampicillin 
overnight culture was prepared with colony number 1. The following day, 2 mls of 
this culture including pTZ57R/T-Motor domain construct, was used for plasmid 
isolation as recommended in Roche, High Pure Plasmid Isolation Kit. Glyserol stock 
was prepared as final concentration would be 20% as mentioned in the Methods 
section. 
Presence of the insert was also confirmed by sequencing with M13F commercially 
available primer. First sequencing PCR was carried out for pTZ57R/T-Motor domain 
construct and then PCR purification for sequencing was performed. The sequencing 
result was checked by using ClustalW alignment program and, 100% similarity was 
observed. 
Alignment of the motor domain in pTZ57R/T cloning vector and original motor 
sequence of Kif 15 was mentioned in table 3.3. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  1   2     3     4     5     6     7 
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Table 3.3:  Alignment results of motor domain in pTZ57R/T cloning vector 
 
orjkif15   -----------------------CAGCCAAGTAACGAAGATGATGCCATCAAAGTTTTTGT 60        
Kif15      -----------------------CAGCCAAGTAATGAAGGTGATGCCATCAAAGTTTTTGT 60     
                                  ************************************** 
                                                                               
orjkif15    GCGGATTCGCCCTGCTGAAGAGGGCGCTAGGTCAGCTGATGGAGAGCAGAGCCTCTGCTT 120      
Kif15       GCGGATTCGCCCTGCTGAAGAGGGCGCTAGGTCAGCTGATGGAGAGCATAGCCTCTGCTT 120       
            ************************************************************ 
orjkif15    GTCTGTGCTCTCCCAGACTGCTCTCCGGCTGCACTCCAACCCAGACCCCAAGACCTTTGT 180               
Kif15       GTCTGTGCTCTCCCAGACTGCTCTCCGGCTGCACTCCAACCCAGACCCCAAGACCTTTGT 180                         
            ************************************************************ 
orikif15    ATTCGATTATGTTGCAGGCATGGACACCACTCAGGAGTCTGTATTTTCAACAGTGGCTAA 240 
kif15       ATTCGATTATGTTGCAGGCATGGACACCACTCAGGAGTCTGTATTTTCAACAGTGGCTAA 240 
            ************************************************************ 
orjkif15    AAGCATTGTGGAGTCTTGCATGAGTGGTTACAACGGGACCATCTTTGCATATGGGCAGAC 300 
Kif15       AAGCATTGTGGAGTCTTGCATGAGTGGTTACAACGGGACCATCTTTGCATATGGGCAGAC 300                
            ************************************************************ 
orjkif15    TGGCTCTGGGAAGACATTTACTATGATGGGACCATCGGACTCTGATAATTTTTCTCATAA 360           
Kif15       TGGCTCTGGGAAGACATTTACTATGATGGGACCATCGGACTCTGATAATTTTTCTCATAA 360                        
            ************************************************************ 
orjkif15    TCTAAGAGGAGTAATTCCACGAAGTTTTGAATATTTGTTTTCCTTAATTGATCGTGAAAA 420 
Kif15       TCTAAGAGGAGTAATTCCACGAAGTTTTGAATATTTGTTTTCCTTAATTGATCGTGAAAA 420 
            *************************************************************** 
 
orjkif15    TTCCAGGTCTCATGCAGTCTTTACAATCACAATAGAATCAATGGAGAAAAGCAGTGAGGC 704 
Kif15       TTCCAGGTCTCATGCAGTCTTTACAATCACAATAGAATCAATGGAGAAAAGCAGTGAGGC 704               
            ************************************************************ 
orjkif15    TGTGAACATTCGGACCTCCTTACTCAACCTGGTGGACTTAGCAGGATCTGAGAGGCAAAA 764 
kif15       TGTGAACATTCGGACCTCCTTACTCAACCTGGTGGACTTAGCAGGATCTGAGAGGCAAAA 764                 
            ************************************************************ 
orjkif15    AGACACCCATGCAGAAGGGATGAGGTTGAAGGAGGCAGGTAACATAAACCGATCACTGAG 824 
Kif15       AGACACCCATGCAGAAGGGATGAGGTTGAAGGAGGCAGGTAACATAAACCGATCACTGAG 824              
            ************************************************************ 
orjkif15    CTGCCTGGGCCAAGTCATCACTGCCCTTGTTGATGTGGGCAATGGGAAACAGAGGCATGT 884 
Kif15       CTGCCTGGGCCAAGTCATCACTGCCCTTGTTGATGTGGGCAATGGGAAACAGAGGCATGT 884                   
            ************************************************************           
orjkif15    CTGCTACCGGGACTCCAAACTTACCTTCTTACTTCGGGACTCCCTTGGTGGCAATGCCAA 944 
Kif15       CTGCTACCGGGACTCCAAACTTACCTTCTTACTTCGGGACTCCCTTGGTGGCAATGCCAA 944             
            ************************************************************ 
orjkif15    AACAGCCATAATTGCAAATGTTCATCCAGGATCCAGGTGTTTTGGGGAAACACTGTCAAC 1004 
kif15       AACAGCCATAATTGCAAATGTTCATCCAGGATCCAGGTGTTTTGGGGAAACACTGTCAAC 1004               
            ************************************************************ 
orjkif15    ACTTAATTTTGCTCAAAGAGCCAAGCTGATTAAAAACAAGGCTGTGGTAAATGAAGACAC 1064 
kif15       ACTTAATTTTGCTCAAAGAGCCAAGCTGATTAAAAACAAGGCTGTGGTAAATGAAGACAC 1064                
            ************************************************************ 
orjkif15    CCAAGGAAATGTGAGCCAGCTACAAGCTGAAGTGAAGAGACTCAGAGAACAACTGTCTCA 1124 
kif15       CCAAGGAAATGTGAGCCAGCTACAAGCTGAAGTGAAGAGACTCAGAGAACAACTGTCTCA 1124 
            ************************************************************ 
 
3.4.4. PCR for tail domain 
Tail domain was amplified from cDNA which was synthesised fom total RNA 
isolated from adult rat brain by using sequence specific primers Tail F and Tail R 
(see Materials and Methods section) Standard PCR was used in amplification as its 
conditions were mentioned in the Methods section. 
 65 
 
Figure 3.10: PCR result of tail domain. 
After PCR, the PCR product was carefully cut out from the gel and following the 
instructions of Qiagen MinElute Gel Extraction Kit, gel extraction was carried out. 
Eluted tail DNA was run on 1% agarose gel in order to observe the extraction 
efficiency. 
 
Figure 3.11: 1% agarose gel photograph  showing the tail domain of Kif15 after gel extraction. 
3.4.5. TA cloning for tail domain. 
Following the gel extraction, tail domain was ligated into pTZ57R/T cloning vector 
by using the InsTATM PCR Cloning Kit (Fermentas). After transformation, 5 white 
and 2 blue colonies  were observed on plate. Based on the blue white secreening 
790bp 
790bp 
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790bp 
principle, 5 white colonies were selected and colony PCR was performed to check if 
these colonies had the insert. Same set of PCR conditions which was used to amplify  
tail domain from cDNA was used in colony PCR reaction. 
 
Figure 3.12: Colony PCR results for tail domain. PCR products in lanes 2,3 and 5 shows that these 
colonies contain the insert 
Colony number 2 was taken to a 5 ml overnight LB-ampicillin culture and the 
following day plasmid was isolated by using High Pure Plasmid Isolation Kit 
(Roche) following the instructions mentioned in methods section. In addition, same 
culture was used to prepare the  glycerol stock as final concentration would be 20%. 
Although the insert’s presence was confirmed by colony PCR, it was also confirmed 
by sequencing with M13F primer. Thus,  sequence PCR then purification of PCR 
product were carried out for  pTZ57R/T -Tail domain construct. 
Sequence result was checked by using ClustalW alignment program. Tail domain’s 
sequence in pTZ57R/T cloning vector was compared with the original Kif15 tail 
domain sequence and 100% similarity was observed. (see table 3.4.) 
 
 
 
 
 
1       2        3       4       5 
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Table 3.4: Sequence alignment of  tail domain in pTZ57R/T 
kif15    ------------GTGATGGGCTCTGCTCCTGAGTATCCACAGAGTCCAAAAACACCACCCCAT   60 
orjkif15 ------------GTGATGGGCTCTGCTCCTGAGTATCCACAGAGTCCAAAAACACCACCCCAT   60 
                     ************************************************* 
kif15       TTTCAAACTCATTTGGCAAAACTCTTGGAAACACAAGAACAAGAGATAGAAGACGGAAGG  120 
orjkif15    TTTCAAACTCATTTGGCAAAACTCTTGGAAACACAAGAACAAGAGATAGAAGACGGAAGG  120                 
            ************************************************************ 
kif15       GCATCTAAGATGTCTTTGCAACACCTCGTCACAAAGCTAAACGAAGACAGAGAAGTCAAA  180 
orjkif15    GCATCTAAGATGTCTTTGCAACACCTCGTCACAAAGCTAAACGAAGACAGAGAAGTCAAA  180                 
            ************************************************************ 
kif15       AACGCTGAAATCCTCAGGATGAAGGATCAGTTGTGTGAAATGGAAAATCTGCGCCTGGAG  240 
orjkif15    AACGCTGAGATCCTCAGGATGAAGGATCAGTTGTGTGAAATGGAAAATCTGCGCCTGGAG  240     
            ************************************************************ 
kif15       TCTCAGCAGTTGAGAGAGAGAACCTGGCTCCTGCAGACTCAGCTGGATGATATGAAGAGG  300 
orjkif15    TCTCAGCAGTTGAGAGAGAGAACCTGGCTCCTGCAGACTCAGCTGGATGATATGAAGAGG  300                 
            ************************************************************ 
kif15       CAGGGGGAGAGCAGCAGTCAGAGTCGTCCAGACAGCCAACAGCTGAAGAATGAATATGAA  360 
orjkif15    CAGGGGGAGAGCAGCAGTCAGAGTCGTCCAGACAGCCAACAGCTGAAGAATGAATATGAA  360                 
            ************************************************************ 
kif15       GAGGAGATTATCAGAGAGAGACTTGCTAAAAATAAACTTATTGAAGAAATGCTAAAAATG  420 
orjkif15    GAGGAGATTATCAGAGAGAGACTTGCTAAAAATAAACTTATTGAAGAAATGCTAAAAATG  420 
            ************************************************************ 
kif15       AAAACAGATCTAGAGGAAGTCCAGAGTGCACTTGACAGCAAGGAGAAGTTCTGCCACAGA  480 
orjkif15    AAAACAGATCTAGAGGAAGTCCAGAGTGCACTTGACAGCAAGGAGAAGTTCTGCCACAGA  480 
            ************************************************************ 
kif15       ATGAGCGAGGAAGTTGAGCGAACCAGAACTTTGGAGTCCAGAGCATTTCAGGAAAAGGAG  540 
orjkif15    ATGAGCGAGGAAGTTGAGCGAACCAGAACTTTGGAGTCCAGAGCATTTCAGGAAAAGGAG  540 
            ************************************************************ 
kif15       CAATTGCGGTCAAAGTTGGAAGAAATGTATGAAGAGAGAGAGAGAACTTGCCAGGAAATG  600 
orjkif15    CAATTGCGGTCAAAGTTGGAAGAAATGTATGAAGAGAGAGAGAGAACTTGCCAGGAAATG  600 
            ************************************************************ 
kif15       GAAATGCTGAGAAAACAACTAGAGTTTCTTGCTGAGGAAAATGGGAAATTGATAGGTCAT  660 
orjkif15    GAAATGCTGAGAAAACAACTAGAGTTTCTTGCTGAGGAAAATGGGAAATTGATAGGTCAT  660    
            ************************************************************                                
kif15       CAAAACCTACATCAGAAGATTCAATATGTAGTGCGACTGAAGAAGGAAAATATCAGGCTT  720 
orjkif15    CAAAACCTACATCAGAAGATTCAATATGTAGTGCGACTGAAGAAGGAAAATATCAGGCTT  720                
            ************************************************************     
kif15       GCTGAGGAGACAGAAAAATTGCGTGCTGAAAATGTATTTTTGAAAGAAAGGAAAAAAGAA  780 
orjkif15    GCTGAGGAGACAGAAAAATTGCGTGCTGAAAATGTATTTTTGAAAGAAAGGAAAAAAGAA  780                
            ************************************************************  
kif15       TGA  
orjkif15    TGA 
            *** 
After completing the sequence alignments, it was observed that motor domain was 
inserted into pTZ57R/T  cloning vector in reverse orientation while tail domain was 
inserted in straight orientation. This information is quite important not only for 
deciding the enzymes which will be used in the restriction reaction, but also for 
deciding the suitable expression vectors. If an insert is in reverse orientation, it has to 
be converted into straight position in expression vector in order to be expressed. 
3.5. Subcloning of  Kif15 motor and tail domains into GFP expression vectors 
3.5.1. Subcloning of motor domain 
Restriction for motor domain and the expression vector chosen, was performed with 
KpnI and PstI restriction enzymes. pEGFP-C1 was chosen as the expression vector 
suitable for motor domain to be inserted. These enzymes and the expression vector 
were chosen by considering the following points: 
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 These enzymes were not cutting the motor domain. 
 Since this domain located in reverse orientation in cloning vector, the cutting 
sites of these enzymes had to be reverse in expression vector. Only then, it 
would be possible to straighten the orientation.(See pTZ57R/T and pEGFP-
C1 restriction maps) 
 These enzymes both cut the cloning and expression vector which is favorable 
in recognition of the cut ends in ligation.  
 pEGFP-C1 had the suitable frame that prevents shifting of the motor domain 
sequence when inserted.                             
Figure 3.13: pEGFP-C1 expression vector, multiple cloning site (MCS) 
 
 
 
Reading frame direction 
Figure 3.14: pTZ57R/T-Motor domain construct 
 
M13F 
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Reading frame direction 
Figure 3.15: pEGFP-C1/Motor domain construct 
By considering these, pTZ57R/T-Motor construct and pEGFP-C1 expression vector 
was cut with PstI and KpnI enzymes. 
 
Figure 3.16: 1st lane: Gel electrophoresis showing the restriction result of  pTZ57R/T-Motor construct 
2nd lane: Gel electrophoresis showing the restriction result of pEGFP-C1 expression vector. 
After restriction, DNA fragments were cut out from the gel and gel extraction was 
performed by using Qiagen MinElute Gel Extraction Kit. In order to check  DNA 
concentrations following gel extraction, 1% agarose gel was used. This is important 
for setting the ligation reaction.  
1 2 
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Figure 3.17: 1st lane: Gel extraction result of  pTZ57R/T-Motor construct, 2nd lane: Gel extraction 
result of  pEGFP-C1 expression vector 
According to these results, concentrations were calculated and ligation reaction was 
set as mentioned in the Methods section. Following ligation, transformation was 
carried out and colonies grown on LB-agar plate were checked to find out if they had 
the insert or not. For this purpose, colony PCR was performed. 
      
Figure 3.18: Colony PCR results for motor domain. 
From the gel, it was observed that most colonies had the insert. Following the colony 
PCR, colony number 4, which is indicated in the 4th lane, was picked for 5ml 
overnight LB –kanamycine culture. The next day, this culture was used for plasmid 
isolation. Following the High Pure Plasmid Isolation Kit (Roche) instructions, 
plasmid isolation was performed and glyserol stock was prpared as menioned before. 
Following plasmid preparation, confirmation restriction was carried out with the 
same enzymes used for restriction reaction.   
1 2 
 1     2      3    4     5     6      7    8     9    10 
1139 bp 
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Figure 3.19: 1% agarose gel showing the confirmation restriction result 
In addition, pEGFP-C1/Motor construct was checked by sequencing with 
commercially available pEGFP-C primer. ClustalW program was used for alignment 
and 100% similarity was observed between the motor domain in expression vector 
and the original motor sequence. (see table 3.5.) 
Table 3.5: Alignment results for motor domain in pEGFP-C1  
 
seq             -----------------------------------------CAGCCAAGTAACGAAGGTG 120 
orj             -----------------------------------------CAGCCAAGTAACGAAGATG 19 
                                                         ******************* 
seq             ATGCCATCAAAGTTTTTGTGCGGATTCGCCCTGCTGAAGAGGGCGCTAGGTCAGCTGATG 180 
orj             ATGCCATCAAAGTTTTTGTGCGGATTCGCCCTGCTGAAGAGGGCGCTAGGTCAGCTGATG 79 
                ************************************************************ 
 
seq             GAGAGCAGAGCCTCTGCTTGTCTGTGCTCTCCCAGACTGCTCTCCGGCTGCACTCCAACC 240 
orj             GAGAGCAGAGCCTCTGCTTGTCTGTGCTCTCCCAGACTGCTCTCCGGCTGCACTCCAACC 139 
                ************************************************************ 
 
 
seq             CAGACCCCAAGACCTTTGTATTCGATTATGTTGCAGGCATGGACACCACTCAGGAGTCTG 300 
orj             CAGACCCCAAGACCTTTGTATTCGATTATGTTGCAGGCATGGACACCACTCAGGAGTCTG 199 
                ************************************************************ 
 
 
seq             TATTTTCAACAGTGGCTAAAAGCATTGTGGAGTCTTGCATGAGTGGTTACAACGGGACCA 360 
orj             TATTTTCAACAGTGGCTAAAAGCATTGTGGAGTCTTGCATGAGTGGTTACAACGGGACCA 259 
                ************************************************************ 
 
seq             TCTTTGCATATGGGCAGACTGGCTCTGGGAAGACATTTACTATGATGGGACCATCGGACT 420 
orj             TCTTTGCATATGGGCAGACTGGCTCTGGGAAGACATTTACTATGATGGGACCATCGGACT 319 
                ************************************************************ 
 
seq             CTGATAATTTTTCTCATAATCTAAGAGGAGTAATTCCACGAAGTTTTGAATATTTGTTTT 480 
orj             CTGATAATTTTTCTCATAATCTAAGAGGAGTAATTCCACGAAGTTTTGAATATTTGTTTT 379 
                ************************************************************ 
 
seq             CCTTAATTGATCGTGAAAAAGAAAAGGCTGGAGCTGGGAAGAGTTTCCTTTGTAAGTGCT 540 
orj             CCTTAATTGATCGTGAAAAAGAAAAGGCTGGAGCTGGGAAGAGTTTCCTTTGTAAGTGCT 439 
                ************************************************************ 
 
seq             CCTTCATTGAGGTCTACAATGAGCAGATATACGACCTGCTGGACTCTGCATCGGTCGGAC 599 
orj             CCTTCATTGAGGTCTACAATGAGCAGATATACGACCTGCTGGACTCTGCATCGGTCGGAC 499 
                ************************************************************ 
 
seq             TGTATTTTAANAGAGCACATAAAAGAAAGGGCGTCCTCCTTGGGTTGGTGCAATGGAAGC 659 
orj             TGTATTTTAAGAGAGCACATAAAAGGAAGGGCGTCTTCGTTGGGTTGGTGCAGTGGAAGC 553 
                ************************************************************ 
 
seq             AGGTGGTGGGCCCCAGCTGCTGAAAGCCTACCAGGTCTTATCTAGAGGCTGGAGGAACA 719 
orj             AGGTGGTGGGCCCCAGCTGCTGAAAGCCTACCAGGTCTTATCTAGAGGCTGGAGGAACA 610 
                *********************************************************** 
pEGFP-C1 
4700 bp 
Motor-1139 bp 
 72 
3.5.2. Subcloning of Tail Domain 
Restriction for tail domain and  pEGFP-C1 expression vector was carried out with 
EcoRI and SmaI restriction enzymes. These enzymes and the expression vector were 
chosen by considering the following points: 
 Tail sequence did not inclue these enzyme’s restriction sites. 
 Since tail domain located in straight orientation in cloning vector, the enzyme 
cutting sites were chosen exactly in the same orientation with the expression 
vector.(See Figure 3.20. and 3.21.) 
 These enzymes both cut the cloning and expression vector which is favorable 
in recognition of the cut ends in ligation.  
 pEGFP-C2 had the suitable frame that prevents shifting of the tail domain 
sequence when inserted (See Figure3.22.).  
 
Figure 3.20: pEGFP-C2 expression vector MCS 
 
 
 
 
                                                                                             Reading frame direction 
 
Figure 3.21: pTZ57R/T cloning vector MCS 
 
  Tail 
M13F 
 73 
 
 
 
 
Figure 3.22: pPEGFP-C2/Tail construct 
By considering these, pTZ57R/T-Tail construct and pEGFP-C2 expression vector 
were cut with EcoRI and SmaI enzymes. 
 
 Figure 3.23: 1st lane: the restriction reaction result for pTZ57R/T-Tail construct, 2nd lane: pEGFP-C2 
expression vector 
These DNAs were cut out from the gel and gel extraction was carried out.  
 
 
Figure 3.24: 1st lane: Gel extraction results for tail domain, 2nd lane: Gel extraction results for 
pEGFP-C2 expression vector 
1 2 
2 1 
Tail 
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After the restriction and gel extraction processes, different ligation reactions were set 
considering the DNA concentration of the vector and the insert. Thus, different insert 
to vector ratios were carried out as mentioned in methods section in order to find the 
most suitable condition. Following ligation, transformation was performed and 
colonies observed on LB-agar plates were checked with colony PCR. 
 
Figure 3.25: Colony PCR results of the tail domain 
Since, all DNA fragments observed in the gel were in expected size,it was concluded 
that all colonies had the insert. 
Colony 3 was selected for overnight LB-kanamycine culture. The following day 
plasmid was isolated by using the High Pure Plasmid Isolation Kit (Roche) and  
glycerol stock for pEGFP-C2/Tail construct  was prepared.  
After plasmid isolation, pEGFP-C2/Tail construct was cut with SmaI and EcoRI for 
confirmation. 
 
Figure 3.26: Confirmation restriction result for tail domain. 
Tail 790bp 
pEGFP-C2 
4700bp 
             1     2     3      4     5     6      7     8     9     10 
790 bp 
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In addition to this confirmation, pEGFP-C2/Tail construct was also confirmed with 
sequecing with commercially available pEGFP-C primer, to show the existance of 
insert in the expression vector.  
After alignment with original Kif15 tail domain sequence, by using ClustalW 
program, 100% similarity was observed. (see table 3.6.) 
Table 3.6: Alignment of tail domain in pEGFP-C2 
tail            TCAGCTCAAGCTTCGAATTCGAGCTCGGTACCTCGCGAATGCATCTAGCTGGAGCACGAG 120 
orj             -----------------------------------------------GCTGGAGCACGAG 11 
                                                               ************* 
 
tail            TGATGGGCTCTGCTCCTGAGTATCCACAGAGTCCAAAAACACCACCCCATTTTCAAACTC 180 
orj             TGATGGGCTCTGCTCCTGAGTATCCACAGAGTCCAAAAACACCACCCCATTTTCAAACTC 71 
                ************************************************************ 
 
tail            ATTTGGCAAAACTCTTGGAAACACAAGAACAAGAGATAGAAGACGGAAGGGCATCTAAGA 240 
orj             ATTTGGCAAAACTCTTGGAAACACAAGAACAAGAGATAGAAGACGGAAGGGCATCTAAGA 131 
                ************************************************************ 
 
tail            TGTCTTTGCAACACCTCGTCACAAAGCTAAACGAAGACAGAGAAGTCAAAAACGCTGAGA 300 
orj             TGTCTTTGCAACACCTCGTCACAAAGCTAAACGAAGACAGAGAAGTCAAAAACGCTGAGA 191 
                ************************************************************ 
 
tail            TCCTCAGGATGAAGGATCAGTTGTGTGAAATGGAAAATCTGCGCCTGGAGTCTCAGCAGT 360 
orj             TCCTCAGGATGAAGGATCAGTTGTGTGAAATGGAAAATCTGCGCCTGGAGTCTCAGCAGT 251 
                ************************************************************ 
 
tail            TGAGAGAGAGAACCTGGCTCCTGCAGACTCAGCTGGATGATATGAAGAGGCAGGGGGAGA 420 
orj             TGAGAGAGAGAACCTGGCTCCTGCAGACTCAGCTGGATGATATGAAGAGGCAGGGGGAGA 311 
                ************************************************************ 
 
tail            GCAGCAGTCAGAGTCGTCCAGACAGCCAACAGCTGAAGAATGAATATGAAGAGGAGATTA 480 
orj             GCAGCAGTCAGAGTCGTCCAGACAGCCAACAGCTGAAGAATGAATATGAAGAGGAGATTA 371 
                ************************************************************ 
 
tail            TCAGAGAGAGACTTGCTAAAAATAAACTTATTGAAGAAATGCTAAAAATGAAAACAGATC 540 
orj             TCAGAGAGAGACTTGCTAAAAATAAACTTATTGAAGAAATGCTAAAAATGAAAACAGATC 431 
                ************************************************************ 
 
tail            TAGAGGAAGTCCAGAGTGCACTTGACAGCAAGGAGAAGTTCTGCCACAGAATGAGCGAG 600 
orj             TAGAGGAAGTCCAGAGTGCACTTGACAGCAAGGAGAAGTTCTGCCACAGAATGAGCGAG 490 
                *********************************************************** 
 
tail            GAAGTTGAGCGAACCAGAACTTTGGGAGTCCAGAGCATTTCAGGAAAAGGGAGCAATTGC 660 
orj             GAAGTTGAGCGAACCAGAACTTTGGCAGTCCAGAGCATTTCAGGAAAAGGGAGCAATTGC 548 
                ************************************************************ 
 
tail            GGTCAAAGTTTGGAAGAAATGTNTGAAGAGAGAGAGAGAACTTGCCAGGAAATGGAAATG 720 
orj             GGTCAAAGTTTGGAAGAAATGTATGAAGAGAGAGAGAGAACTTGCCAGGAAATGGAAATG 607 
                ************************************************************ 
 
tail            CTGAAAAAACAACTAGAGTTTCTTGCTGAGG----------------------------- 751 
orj             CTGAAAAAACAACTAGAGTTTCTTGCTGAGGAAAATGGGAAATTGATAGGTCATCAAAAC 667 
                *******************************                               
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4. DISCUSSION 
4.1. RNA isolation from adult rat brain tissue 
RNA isolation from adult rat brain was performed twice, since there were no claer 
RNA observed on the gel after the first trial. (see figure 4.1.) The possible reasons 
could be RNA degredation, unsatisfactory cell disruption or inadequate starting 
amount of brain tissue.  
Undesirable RNAases readily found in the environment could cause RNA 
degradation. In addition, since cell disruption and homogenization are the first and 
one of the most critical steps affecting yield and quality of the isolated RNA, 
unsatisfactory cell disruption and homogenization could lead to this problem. 
Another possibility could be the inadequate tissue amount. Since the brain tissue 
amount needed for RNA isolation was very little, maybe the needed amount was not 
decided properly by estimation.  
After the second trial, two clear RNA fragments were observed on the gel. (see 
figure 4.1.) Although the yield of the RNA did not seem to be perfect, since it was 
intact, this RNA was used for cDNA synthesis and satisfactory results were obtained 
in the control PCR reaction. 
Spectrophotometric RNA concentration measurement was not performed because the 
integrity of the RNA could not be understood by measuring the concentration of the 
RNA. Hence,  based on the spectrophotometric analysis, the result could have been 
fallacious, and since degraded RNA could not be used for cDNA synthesis, the gel 
result was taken into consideration.  
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                                                  -A-                 -B- 
Figure 4.1: A) Result of the RNA isolation after first trial. Arrow indicates the slight RNA fragments 
which should have been clear and intact  B) Result of the RNA isolation after second trial. Arrows 
indicate the 18S and 28S rRNAs    
4.2. Cloning of Motor Domain 
In order to amplify motor domain from the cDNA; the following PCR program 
(program no:1, see table 4.1.) with the amounts previously mentioned in the Methods 
section was performed and the PCR result mentioned in figure 4.2. was obtained. 
                            Table 4.1: PCR run program for motor domain No:1 
Program No:1 
Initial Denaturation 94°C 30 sec 
Denaturation 94°C 1 min 
Annealing 55°C 1 min 
Elongation 72°C 2 min 
Final Elongation 72°C 5 min 
 
 
40 cycles 
Note:  Melting temperatures (Tm) for motor domain’s forward and reverse primers were 
62°C and 66°C respectively. 
 
 
 
 
 
 
 
 
Figure 4.2:  Agarose gel photograph showing the result of motor domain PCR from the cDNA. 
28S 
18S 
Motor domain 
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After this PCR although there were some unspecific products (most probably primer 
dimers), since the motor domain DNA was clearly observed in the correct size on the 
gel, gel extraction was performed for this fragment. Following the gel extraction, 
eluted DNA was run on a 1% agarose gel as shown in figure 4.3. 
                 
Figure 4.3: Gel extraction result for motor domain. 
DNA observed on the gel after gel extraction  was slightly visible. Although Roche 
High Pure Plasmid Isolation Kit was used for plasmid preparation and every step of 
the process was followed carefully, generally it was observed that the DNA 
concentration after gel extraction was always a lot lower than the concentration at the 
begining. Since the beginning concentration of the DNA obtained after PCR 
amplification is low itself, this gel extraction result was reasonable. In addition, since 
the contribution of excessive gel pieces is highly possible and it directly effects the 
yield and quality of the DNA obtained after the process, this could also be a reason 
for unsatisfactory gel extraction result. 
In order to optimize the PCR reaction, several different PCRs were performed by 
changing the conditions PCR reactions. Especially annealing temperatures were 
changed. Since the optimum amount of cDNA used as a template in these  reactions 
was decided by control PCR reaction mentioned in the results section, this amount 
was not changed. In addition, no significant changes were carried out for other PCR 
contents. 
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10 cycles 
each 
Considering the Tm values of the primers designed for motor domain, the cDNA 
synthesized from the whole rat brain RNA was used as a template and annealing 
temperature of the programs was changed from 56°C to 62°C by increasing 1°C in 
each PCR in order to find the optimum annealing temperature. The reason why we 
increase the annealing temperatures is that higher temperatures minimize nonspecific 
primer annealing and increase the amount of specific products produced while  
reducing the amount of primer-dimer formation.  
No satisfactory results were obtained from these trials. Since there were no DNA 
fragments, even slight, and only DNA observed on gels were primer-dimers, it was 
thought that the reason of these results could be the primers that could not anneal  to 
the desired sequences. Thus, in order to find the optimum annealing temperature, 
firstly a touch-down PCR was performed with annealing temperatures starting from 
60°C and decreased to 54°C and since no results were obtained after touch-down 
PCR, secondly, a new PCR program (program no:2) in which annealing temperatures 
were gradually increased from 54°C to 58°C considering the same idea behind 
increasing the annealing temperatures 1°C in each PCR, while searching for the 
suitable annealing temperature was performed for motor domain as shown in table 
4.2. By using this program PCR result mentioned in figure 4.4. was obtained. 
Table 4.2: PCR run program for motor domain No:2 
Program No: 2 
Initial Denaturation 94 1 min.  
Denaturation 94 30 sec. 94 30 sec. 94 30 sec. 94 30 sec. 94 30 sec. 
Annealing 54 1 min. 55 1 min. 56 1 min 57 1 min. 58 1 min. 
Elongation 72 2 min. 72 2 min 72 2 min 72 2 min. 72 2 min. 
Final Elongation 72 10 min.  
Note: All values are °C. 
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Motor domain 
 
 
 
 
 
 
Figure 4.4: Agarose gel showing the PCR result 
PCR product in expected size was obtained but a DNA smear was also observed on 
gel. The reasons of such smear could be inappropriate template amount or impurity. 
Since the DNA fragment in expected size was clearly observed in spite of the smear, 
this fragment was cut carefully and gel purified in order to be used as a template in a 
new reaction. Hence, if the problem was purity we would have had a purer template 
for next reactions. In addition, since the gel result (see figure 4.4.) prooved that the 
fragment observed on gel was certainly our interested domain and since it was once 
amplified from cDNA, by using the same primers we could increase the annealing 
probability of primers and better results could be obtained than PCR results which 
cDNA was used as a template. Moreover, the DNA which was amplified from cDNA 
and gel purified (see fig. 4.3.) was also used as a tempate in a new reaction. Thus 2 
new PCRs by using 2 different gel extracted DNAs as templates were perormed by 
using program 2 as shown in figure 4.5.  
                                                      
Motor 
domain 
A B 
 81 
Figure 4.5: A) PCR result, where DNA extracted from the gel in Figure 4.4 was used as a template. 
B) PCR result, where DNA in Figure 4.3. was used as a template 
After checking the PCR products on gel, a slight DNA fragment was observed for the 
first reaction and a  clear DNA fragment was observed for the second reaction. Thus, 
the second one was gel purified (see figure 4.6.) and used in TA cloning reactions. 
 
Figure 4.6: Gel extraction result for second reaction 
4.3. Subcloning of motor and tail domain into GFP vectors 
After deciding the suitable enzymes and vectors that should be used for subcloning, 
related GFP vectors and pTZ57R/T constructs were digested with the enzymes 
mentioned in the methods section.  
Digestion reactions were run on the agarose gel in order to cut out the insert and GFP 
vector for further applications (gel extraction and then ligation). 
Several restriction and ligations were performed in order to obtain desired results. 
 
 
 
 
 
 82 
pEGFP-C1 
4.3.1. Optimization for subcloning of  motor domain into GFP vector 
In the first trial, appropriate vector (pEGFP-C1) and insert (pTZ57R/T-Motor 
construct) DNAs were  cut with KpnI ad PstI enzymes. Following digeston, the 
results were checked on gel as shown in figure 4.7. 
 
Figure 4.7: Gel electrophoresis showing the result of digestion reaction for motor domain 
After digestion, gel extraction was performed as shown in figure 4.8. 
 
Figure 4.8: Gel extraction result for motor domain. 
Since the vector DNA concentration observed on gel was insufficient for ligation 
reaction, more vector was digested.(see figure 4.9.).Following this step gel extraction 
was performed as mentioned in figure 4.10.  
 
Figure 4.9: Restriction result for pEGFP-C1 expression vector. 
pTZ57R/T 
Motor domain 
pEGFP-C1 
Motor domain 
pEGFP-C1 
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pEGFP-C1 
 
Figure 4.10: Gel extraction result for pEGFP-C1 expression vector. 
After the gel extraction for pPEGFP-C1 vector, since the concentration observed was 
sufficient on gel, 3 different ligation reactions were set as mentioned below in table 
4.3. 
Table 4.3: 3 Different ligation reactions for motor domain 
 
          Incubated overnight (O/N) at room temperature (RT)                         Incubated O/N at 4°C 
 
 
 
1st ligation reaction 
 
2nd ligation reaction 
 
3rd ligation recation 
 
Content Amount- 
µl 
Content Amount- 
µl 
Content Amount- 
µl 
pEGFP-C1 
(100ng) 
5 pEGFP-C1 1 pEGFP-C1 2 
Motor domain 
(25ng) 
12 Motor domain 5 Motor domain 8 
  10X ligation 
buffer 
2 10X ligation 
buffer 
1 * 
T4 ligase 1 T4 ligase 0.5 10X ligation 
buffer 
2 
  
dH2O 2.5 T4 ligase 3 
  
  PEG 2 
    
dH2O 3 
Total reaction 20 
 
Total reaction 10 
 
Total reaction 20 
*Insert and vector were mixed and put at 65°C for 5 
min. Then they were put on ice for 10 min. 
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Motor domain  
 
 In the first ligation reaction, insert amount was selected as almost 3 three fold 
excess of the vector’s amount as usually recommended in ligation reactions.  
 In the second reaction, 5 five fold excess insert was added to the mixture, in 
order to increase the possibility of integration.  
 In the third reaction, 4 fold excess insert was used. In addition PEG was used. 
Because PEG is a volume excluder, hence your DNA and enzyme are 
concentrated into a smaller volume than you set up and this increases the 
ligation efficiency. The reason of the incubation of the vector and insert at  
65°C is to facilitate the denaturation of the helices and putting them on ice 
after denaturation is to increase the possibility of the integration.  
Since no satisfactory  results were obtained after transformations performed for these 
ligations, this time  it was decided to digest more motor construct in order to increase 
the concentration obtained after gel extraction. Result after restriction is shown 
below in figure 4.11. 
   
Figure 4.11: Agarose gel electrophoresis showing the restriction result of the construct. 
After restriction, motor domain was cut out from the gel and gel extraction was 
performed as shown in figure 4.12. 
 
Figure 4.12: Agarose gel electrophoresis showing the gel extraction result of the motor domain  
pTZ57R/T 
Motor domain  
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Following this digestion and gel extraction, motor DNA obtained from this gel 
extraction and pEGFP-C1 vector mentioned in figure 10 were used in different 
ligation reactions as shown in table 4.4.                     
Table 4.4: 5 Different ligation reactions for motor domain 
            
 
 
 
 
 
 
 
 
 
 
                                Incubated O/N at 16°C                         Incubated O/N at  4°C  
 
 
 3rd ligation reaction 4th ligation reaction 5th ligation reaction 
Content Amount- µl Amount- µl Amount- µl 
pEGFP-C1 1  2  1  
Motor domain 7  9 7  
10X ligation buffer 1  1.5  1.5  
T4 ligase 1  1  2  
PEG - 1.5  1.5  
dH2O - - 2  
Total reaction 10  15  15  
                                                                                                                                                                 
                                           O/N- RT                       O/N -4°C                       O/N-RT 
In the first and second reactions vector to insert ratios were kept constant and ligase 
and PEG concentrations were increased. In addition, the ligation reactions were 
performed at different temperatures.  
 
1st ligation reaction 
 
2nd ligation recation 
 
Content Amount- µl Content Amount- µl 
pEGFP-C1 2 pEGFP-C1 2 
Motor domain 8 Motor domain 8 
                                 *                                 * 
10X ligation buffer 1,5 10X ligation buffer 2
T4 ligase 1 T4 ligase 1.5 
PEG 0.5 PEG 2 
dH2O 2 dH2O 4.5 
Total reaction 15 
 
Total reaction 20 
*Insert and vector were mixed and put at 65°C for 5 
min. Then they were put on ice for 10 min. 
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  pEGFP-C2 
 Tail domain 
  pEGFP-C2 
Tail domain 
In the other ligation reactions, 7 and 2,5 fold excess inserts were put into the reaction 
with or without PEG and the amount of enzyme in 5th reaction was increased twice. 
These changes were performed in order to find the optimum conditions for ligation 
reaction. In addition, since there are different temperatures recommended for ligation 
reactions in the literature, the temperatures widely used in these reactions were 
selected, and room temperature, 4°C,16°C were used.  
No satisfactory results were obtained from these ligations. Since many different 
ligation reaction conditions and different vector to insert ratios were tried, it was 
thought that the digestion should be repeated. Since we used the same enzymes to cut 
out the insert from cloning vector and to open up the expression vector, it was 
thought that there were not any problems about the enzymes and buffers used. Thus, 
the digestions were repeated (especially to be sure of the complete digestion of the 
vector) as mentioned in the methods section and desired results were obtained. 
4.3.2. Optimization for subcloning of  tail domain into GFP vector 
Appropriate amounts of pTZ57R/T-Tail construct and the pEGFP-C2 vector were 
digested with EcoRI and SmaI enzymes.(see figure 4.13.). After digestion, gel 
extraction was performed for both insert and expression vector and the results of 
extraction were checked on gel as shown in figure 4.14. 
 
Figure 4.13: Restriction results for tail domain. 
 
Figure 4.14: Agarose gel electrophoresis showing the result of the gel extraction after restriction. 
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According to the concentrations of the insert and vector observed on the gel after the 
gel extraction, different ligation reactions were performed as mentioned below in 
table 4.5. 
Table 4.5: 4 different ligation reactions for tail domain 
 
 
 
 
In the first trial, since the DNA concentration of the insert was lower than the vector, 
6  fold excess insert was used for the reaction. Since there were no results, 3,4 and 7 
fold excess inserts were also used for following reactions. 
PEG 4000 was used to increase the efficiency of the ligation reaction by increasing 
the possibility of recognition of the restricted ends of the tail and the pEGFP-C2 to 
each other. Since SmaI creates blunt ends and EcoRI creates sticky ends, PEG 4000 
was used in every reaction in different amounts. In addition, based on the fact that 
increasing amount of ligase enzyme has positive effects on ligation reaction, enzyme 
amount was increased gradually. After these ligations, since no satisfacory results 
were obtained, the following ligation reactions mentioned in table 4.6. were carried 
out. 
 
 
 
 
1st ligation 
reaction 
2nd ligation 
reaction 
3rd ligation 
reaction 
4th ligation 
reaction 
Content Amount- µl Amount- µl Amount- µl Amount- µl 
pEGFP-C2 1 2 1 2 
Tail domain  6 6 7 8 
10X ligation 
buffer 
1  1.5 1.5 2 
PEG 4000 1  1 2 1.5 
T4 DNA ligase 1  1.5 2 3 
dH2O - 3 1.5 3.5 
Total reaction: 10 15 15 20 
Incubated O/N at RT Incubated O/N at 16°C 
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Table 4.6: 2 different ligation reactions for tail domain 
 
 
 
 
 
 
 
 
 
 
 
 
 
In this procedure, the principle is to increase the possibility of the integration of the 
insert into the expression vector, as mentioned in optimization for motor domain. For 
this reason, two different ligation reactions were performed. 3 or 4 fold excess  insert 
was used in two different reactions respectively. In addition the enzyme amount was 
increased and the incubation temperature was changed. These reactions did not give 
satisfactory results. Finally, ligation reactions mentioned in the methods section 
worked properly and it was seen that 1:7 and 1:3,5 vector to insert reatios worked 
best for tail domain. 
 
1st ligation reaction 
 
2nd ligation recation 
 
Content Amount- µl Content Amount- µl 
pEGFP-C2 2 pEGFP-C2 2 
Tail  domain 6 Tail domain 8 
                                    *                                     * 
10X ligation buffer 2 10X ligation buffer 2 
T4 ligase 2 T4 ligase 3 
PEG 2 PEG 2 
dH2O 6 dH2O 3 
Total reaction 20 
 
Total reaction 20 
           Incubated O/N at RT         Incubated O/N at 4°C 
*Insert and vector was mixed and put at 65°C for 5 min. 
Then they were put on ice for 10 min. 
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5. CONCLUSION 
Since Kif 15 is a motor protein whose functions are crucial for both neuronal and 
non-neuronal cells, in this study, we aimed to dissect this motor protein into its 
functional domains in order to understand the interactions of these domains with 
other cytoskeletal elements. To achieve our goal, first of all we successfully isolated 
whole RNA from adult rat brain. Then, cDNA was successfully synthesized from 
RNA and functional domains of Kif15 (motor, myosin interacting and tail domains) 
were cloned from this cDNA by using sequence specific primers. These PCR 
products were ligated into cloning vectors in order to carry out further processes. 
After checking the insert existence by sequencing method, finally these domains 
were successfully subcloned into GFP vectors in order to track in cell culture studies.  
Since Kif 15 functions to maintain the spindle poles during mitosis in mitotic cells, 
and it is thought that it uses a similar mechanism in ending the neuronal migration, 
both cell types will be used in cultures. For non-neuronal cell culture studies, HeLa 
cells will be used. For neuronal cell culture studies, adult rat hippocampus cells and 
will be used. In these cultures, Kif 15 and other cytoskeletal elements (MT, MF, 
other motors etc.) will be analyzed stained by using immunostaining techniques. 
Then, it will be possible to reveal the interactions of Kif 15’s functional domains 
with other cytoskeletal elements.   
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